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Chapter 1 
 
Mitomycin C 
 
1.1. Mitomycin Family of Natural Products 
 The mitomycins were discovered in 1956 when mitomycins A (MMA, 1) and B 
(MMB, 2) were isolated from Streptomyces caespitosus (Figure 1).
1
 In 1958, mitomycin 
C (MMC, 3) was isolated by Wakaki and coworkers from the same strain. In 1960, 
porfiromycin (4) was isolated from Streptomyces ardus and in 1962, all four compounds 
were isolated from Streptomyces verticillatus.
2,3
  
 
 
                                                 
1
 Hata, T.; Sano, R.; Sugawara, A.; Matsume, K.; Shima, T.; Hoshi, T. J. Antibiot. 1956, 9, 141-146. 
2
 Lefemine, D. V.; Dann, M.; Barbatschi, F.; Hausmann, W. K.; Zbinovsky, V.; Monnikendam, P.; Adam, 
J.; Bohonos, N. J. Am. Chem. Soc. 1962, 84, 3184-3185.  
3
 Webb, J. S.; Cosulich, D. B.; Mowat, J. H.; Patrick, J. B.; Broschard, R. W.; Meyer, W. E.; Williams, R. 
P.; Wolf, C. F.; Fulmor, W.; Pidacks, C.; Lancaster, J. E. J. Am. Chem. Soc. 1962, 84, 3185-3187. 
Figure 1. Classification of Mitomycin Family 
 
 
2 
 
 The mitomycin family of alkaloids is characterized by a tetracyclic aziridino-
pyrrolo-indole skeleton and can be further classified into three groups, namely A, B and 
G, named after the first mitomycin isolated in that group. The most abundant mitomycins 
are represented in Figure 1. Mitomycins A and B both have a carbamoyloxymethyl side 
chain and are epimeric at the carbon bearing the side chain. The presence of the quinone, 
carbamoyl and aziridine functional groups, and their spatial relationships are important to 
their anti-tumor activity. The members of the mitomycin G class have a methylene side 
chain.
5
  
 Additional nomenclature identifying the skeletal oxidation state and the 
numbering system of the mitomycin family is shown in Figure 2.
4
 Mitosenes and 
mitosanes consist of the p-quinone and are at the indole and indoline oxidation states 
respectively. A mitosane with an intact aziridine ring is called an aziridinomitosane. 
Mitomycins that are in the hydroquinone form are prefixed by the term leuco (Greek 
leucos: white, clear).
5
  
 
                                                 
4
 Remers, W. A.; Dorr, R. T. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.; 
Wiley-Interscience: New York, 1988; Vol. 6, p 1. 
5
 Andrez, J.-C. Beilstein J. Org. Chem. 2009, 5. 
3 
 
 
 The mitomycins are highly colored and crystalline. The quinone chromophore 
gives distinct colors based on its substitution: mitomycin A (1) with one amino group and 
one methoxy group is reddish-violet, mitomycin C (3) with two amino groups is blue. 
Mitosane conversion to mitosenes is accompanied by a color change to purple and 
orange, respectively, because of the extended indoloquinone chromophore.
4
  
 After a series of revisions, the absolute configuration of mitomycin C was 
established to be (1S, 2S, 9S, 9aR) by anomalous dispersion X-ray crystallography. 
Biosynthetic studies were consistent with these results.
6,7,8,9
 
 
1.2. Biosynthesis 
 Biosynthetic studies of the mitomycins established that the O-methyl group came 
from L-methionine by feeding [methyl-
14
C]-L-methionine to Streptomyces verticillatus 
(Figure 3). The origin of the carbamoyl group was determined to be L-arginine, which 
                                                 
6
 Tulinsky, A.; Van den Hende, J. H. J. Am. Chem. Soc. 1967, 89, 2905-2911.  
7
 MMB: Yahashi, R.; Matsubara, I. J. Antibiot. 1976, 29, 104-106. 
8
 Relationship between MMA, B and C: Hornemann, U.; Heins, M. J. J. Org. Chem. 1985, 50, 1301-1302.  
9
 Revised MMC structure: Shirahata, K.; Hirayama, N. J. Am. Chem. Soc. 1983, 105, 7199-7200. 
Figure 2. Nomenclature and Numbering of Mitomycin Skeleton 
 
 
4 
 
was first hydrolyzed to citrulline and then converted to carbamoyl phosphate before 
incorporation into the mitomycins. 
14
C-labeling of the guanidine group of arginine and 
the ureido group of citrulline showed the incorporation of the labeled ureido group of 
citrulline into MMA and MMB.
10,11,12,13
 
 
 
 Labeling and degradative studies of D-glucosamine indicated incorporation into 
the aziridinopyrrolidine carbon skeleton with the amino group being converted to the 
aziridine ring (Figure 3).
14
 This is in contrast to other natural products containing 
aziridines like azinomycins and azicemicins that utilize a glutamate or ornithine 
                                                 
10
 Lowden, P. A. S. In Aziridines and Epoxides in Organic Synthesis; Yudin, A. K., Ed.; Wiley-VCH: 
Weinheim, 2006, p 399-442.  
11
 Hornemann, U.; Cloyd, J. C. J. Chem. Soc. D 1971, 301-302. 
12
 Hornemann, U.; Eggert, J. H. J. Antibiot. 1975, 28, 841-843. 
13
 Bezanson, G. S.; Vining, L. C. Can. J. Biochem. 1971, 49, 911-918. 
14
 Hornemann, U.; Kehrer, J. P.; Nunez, C. S.; Ranieri, R. L. J. Am. Chem. Soc. 1974, 96, 320-322. 
Figure 3. Biosynthetic Map for Mitomycin C 
 
 
5 
 
derivative and aspartic acid respectively to generate the aziridine unit.
15
 Aziridine 
formation is hypothesized to occur through an intramolecular SN2 reaction.
10,16
 The 
quinone ring of the mitomycins was derived from 3-amino-5-hydroxybenzoic acid 
(AHBA).
17
 AHBA is primarily known as the universal precursor of ansamycin antibiotics 
and the biosynthetic pathway for its formation has been reviewed.
18
 Analysis of the 
biosynthetic gene cluster in Streptomyces lavendulae revealed the presence of four 
coenzyme F420-dependent tetrahydromethanopterin reductase genes and one 
tetrahydromethanopterin-CoM methyltransferase gene.
19
 Similar to methanogenic 
bacterial genes responsible for reduction of CO2 to CH4, these may be involved in the 
reduction of the carboxyl group of AHBA to the C6 methyl group. Three SAM-
dependent methyltransferases that could be involved in addition of O- and N-methyl 
groups were identified. Two cytochrome P450 genes that could be responsible for 
hydroxylation at C5 and C7 were also found. 
 Since antibiotic resistance genes are often clustered with the biosynthetic genes, 
the genes conferring resistance to mitomycin upon the producing organism were also 
investigated. A MMC resistance gene (mcrA) responsible for producing a flavoprotein 
MCRA that covalently binds FAD cofactor was found which possibly confers resistance 
to MMC by oxidizing the reductively activated form of MMC. A MMC-specific drug 
export system is believed to be formed by the conjunction of a small soluble protein 
                                                 
15
 Ogasawara, Y.; Liu, H.-w. J. Am. Chem. Soc. 2009, 131, 18066-18068. 
16
 Enzyme catalyzed SN2 reactions review: O'Hagan, D.; Schmidberger, J. W. Nat. Prod. Rep. 2010, 27, 
900-918. 
17
 Anderson, M. G.; Kibby, J. J.; Rickards, R. W.; Rothschild, J. M. J. Chem. Soc., Chem. Commun. 1980, 
1277-1278. 
18
 Floss, H. G.; Yu, T.-W.; Arakawa, K. J. Antibiot. 2011, 64, 35-44. 
19
 Mao, Y.; Varoglu, M.; Sherman, D. H. Chem. Biol. 1999, 6, 251-263. 
6 
 
(Mrd)) that binds MMC noncovalently, thus preventing it from being activated, along 
with Mct, a membrane-bound MMC transport protein.
19,28
  
 
1.3. Mechanism of Action 
 The mechanism of action of mitomycin C has been well studied and is 
summarized in Figure 4. Upon reductive activation in the cell, intermediate 6 
spontaneously loses methanol to form the leucoaziridinomitosene 7. Protonation of the 
aziridine results in aziridine ring opening and the formation of quinone methide 8 which 
is then alkylated by DNA at the C1 position. A retro-Michael elimination of the 
carbamate results in the formation of a second alkylating center at C10 (10) which is 
attacked by DNA to form the cross-linked adduct (11).
5,20,21,22
 The initial reductive step 
can proceed via a one-electron or a two-electron reduction to the semiquinone or the 
hydroquinone, respectively. Recent work has indicated that the semiquinone species is 
more likely to form than the hydroquinone.
23,24,25,26,27
 
 
                                                 
20
 Tomasz, M. Chem. Biol. 1995, 2, 575-579. 
21
 Moore, H. W. Science 1977, 197, 527-532. 
22
 Szybalski, W.; Iyer, V. N. In Antibiotics I, Mechanism of Action; Gottlieb, D., Shaw, P. D., Eds.; 
Springer-Verlag: New York, 1967; Vol. 1, p 211-245. 
23
 Egbertson, M.; Danishefsky, S. J. J. Am. Chem. Soc. 1987, 109, 2204-2205. 
24
 Andrews, P. A.; Pan, S. S.; Bachur, N. R. J. Am. Chem. Soc. 1986, 108, 4158-4166. 
25
 Danishefsky, S.; Ciufolini, M. J. Am. Chem. Soc. 1984, 106, 6424-6425. 
26
 Suresh Kumar, G.; Lipman, R.; Cummings, J.; Tomasz, M. Biochemistry 1997, 36, 14128-14136. 
27
 Kohn, H.; Zein, N.; Lin, X. Q.; Ding, J. Q.; Kadish, K. M. J. Am. Chem. Soc. 1987, 109, 1833-1840. 
7 
 
 
 The selectivity of MMC for tumor cells lies in its reductive bioactivation. MMC 
itself is inert to DNA and serves as a noncytotoxic prodrug.
28
 The reduction of the 
quinone in MMC leads to a cascade of spontaneous transformations that culminate in the 
alkylation and crosslinking of DNA. The reducing environment required to activate 
MMC is mostly found in hypoxic solid tumor cells, which are otherwise resistant to most 
other chemotherapeutic treatments, and this makes MMC successful in certain cancer 
lines such as colon, breast and lung.
28,29
 Once activated, MMC acts as a bifunctional 
alkylating agent and crosslinks DNA. Monoalkylation alone is not necessarily lethal in 
mammalian cells; it is this bifunctionality of MMC that allows it to readily crosslink 
DNA which results in cell death, thereby making it a potent antitumor drug.
20
 
                                                 
28
 Galm, U.; Hager, M. H.; Van Lanen, S. G.; Ju, J.; Thorson, J. S.; Shen, B. Chem. Rev. 2005, 105, 739-
758. 
29
 Sartorelli, A. C. Biochem. Pharmacol. 1986, 35, 67-69. 
Figure 4. Mechanism of Action of Mitomycin C 
 
 
8 
 
 The isolation of monoalkylated and crosslinked MMC-
DNA adducts showed MMC residing in the minor groove of 
DNA without greatly perturbing the structure of duplex DNA. 
MMC is selectively bound by the N2 group of guanine. Both 
alkylation and crosslinking are sequence-specific for the CpG 
sequence (5’-C-phosphate-G-3’). MMC requires two guanine residues on opposite 
strands to make a crosslink. The N2-amino group of the opposite strand guanine forms a 
specific H-bond with the C10 oxygen atom of activated MMC (Figure 5). This increases 
the rate of monoalkylation and the monoadduct is now poised to make the crosslink 
without significant structural reorganization of the DNA.
 20,30
 
 
1.4. Previous Syntheses of Mitomycin C 
 Mitomycin C has proven to be a challenging target for synthetic chemists. Despite 
numerous synthetic efforts towards MMC and syntheses of mitomycin K, only two total 
syntheses of MMC have been achieved so far.  
 Kishi completed the first total synthesis of racemic MMC in 1977. In designing 
his synthesis, Kishi noted that the least stable functionality of the mitomycins (the C9a 
N,O-ketal) was to be introduced at a late stage of the synthesis, after which the oxidation 
state of the intermediates needed to be maintained at the indole quinone to avoid 
elimination of this acid-sensitive moiety.
31
 To meet these requirements, the key reaction 
was the installation of the C9a N,O-ketal in a transannular cyclization of eight-membered 
                                                 
30
 M Tomasz, R. L., D Chowdary, J Pawlak, GL Verdine, and K Nakanishi Science 1987, 235, 1204-1208. 
31
 Kishi, Y. J. Nat. Prod. 1979, 42, 549-568. 
Figure 5. Schematic 
Illustration of Sequence-
Selectivity 
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ring 16. The eight-membered ring 16 itself was to be prepared by a Michael addition of 
the amine into the quinone (Scheme 1).  
 
 
 Compound 12, obtained in three steps from commercially available 2,6-
dimethoxytoluene, was allylated and then transformed to compound 13. The methyloxy 
group (C10) was installed using a formaldehyde aldol (Scheme 1). A mild three step 
protocol was required to protect the ketone as the dimethyl ketal to prevent elimination of 
the protected C10 alcohol group.
32
 The olefin in 14 was transformed to the aziridine in 15 
by epoxide formation, followed by regioselective opening with lithium azide, Staudinger 
reduction and intramolecular substitution by the resulting amine.
33
 Hydrogenolysis to 
remove the benzyl groups, air oxidation to the quinone with the concomitant Michael 
addition resulted in the formation of key intermediate 16. Transannular cyclization was 
affected using tetrafluoroboric acid via the nucleophilic trapping of the oxonium 
intermediate, formed in situ from the ketal, by the pendant amine. Carbamoylation and 
                                                 
32
 Nakatsubo, F.; Cocuzza, A. J.; Keeley, D. E.; Kishi, Y. J. Am. Chem. Soc. 1977, 99, 4835-4836. 
33
 Nakatsubo, F.; Fukuyama, T.; Cocuzza, A. J.; Kishi, Y. J. Am. Chem. Soc. 1977, 99, 8115-8116. 
Scheme 1. Kishi’s Synthesis of (±)-Mitomycin C 
 
 
10 
 
deprotection gave MMA, which upon ammonolysis gave MMC.
34
 MMC was thus 
prepared in 44 steps from phenol 12 with an overall yield of 0.16% (47 steps from 2,6-
dimethoxytoluene).
5
 The high number of steps arises primarily from protecting group 
manipulations (for example: six steps to install and remove the aziridine protecting 
group) and certain functional group manipulations (for example: six steps to construct the 
aziridine). However, the synthetic strategy was a carefully designed assembly of the 
highly reactive components of MMC and led to the first successful synthesis. 
 The second and only other total synthesis of MMC was completed by Fukuyama 
in 1987. Kono reported the isolation of isomitomycin A (18) and albomitomycin A in 
1987 (19); the equilibrium between these two compounds and MMA (1) was termed the 
mitomycin rearrangement (Scheme 2).
35
 Fukuyama’s approach to MMC utilized the fact 
that isomitomycin A contained the acid-sensitive C9a methoxy group attached to the less 
reactive bridgehead carbon therefore making it possible to install the C9a methoxy group 
at an earlier stage.  
 
 
 Fukuyama’s synthesis (Scheme 3) started with chalcone 20 (obtained in 13 steps 
from 2,6-dimethoxytoluene, 45% overall yield).
36
 Michael addition of furan 21 gave the 
                                                 
34
 Fukuyama, T.; Nakatsubo, F.; Cocuzza, A. J.; Kishi, Y. Tetrahedron Lett. 1977, 18, 4295-4298. 
35
 Kono, M.; Saitoh, Y.; Shirahata, K.; Arai, Y.; Ishii, S. J. Am. Chem. Soc. 1987, 109, 7224-7225. 
36
 Fukuyama, T.; Yang, L. Tetrahedron Lett. 1986, 27, 6299-6300. 
Scheme 2. The Mitomycin Rearrangement 
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silyl enol ether 22. An intramolecular azide-olefin [3+2] addition followed by in situ N2 
evolution gave aziridine 23. After conversion to 24, careful treatment with 0.3 
equivalents CSA in methanol installed the methoxy group via the highly strained iminium 
ion 25. Hydrogenolysis and oxidation to the quinone gave isomitomycin A (19). 
Treatment with ammonia in methanol gave isomitomycin C (27) that rearranged to give 
MMC (3).
37,38
 MMC was thus prepared in a total of 25 steps from 2,6-dimethoxyltoluene 
in an overall yield of 10%.
5
 
 
 
                                                 
37
 Fukuyama, T.; Yang, L. J. Am. Chem. Soc. 1987, 109, 7881-7882.  
38
 Fukuyama, T.; Yang, L. J. Am. Chem. Soc. 1989, 111, 8303-8304. 
Scheme 3. Fukuyama’s Synthesis of Mitomycin C 
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1.5. Syntheses of Mitomycin K 
 Mitomycin K (5, Figure 6) is another relatively simpler synthetic target from the 
mitomycin family, as it lacks the C9 stereochemistry seen in MMC. Danishefsky’s 
synthesis of mitomycin K utilized an intramolecular 
cycloaddition of a dienyl nitroso substrate 28 (Scheme 4).
39
 In 
essentially one step, the mitomycin skeleton was rapidly 
assembled including the N,O-ketal moiety and the olefin 
required for aziridine preparation. Azide-olefin addition gave triazoline 30, that was then 
photolytically decomposed to give the requisite aziridine for mitomycin K.
40,41 
 
 
 Jimenez’s synthesis of mitomycin K built the mitomycin skeleton starting from 
highly substituted indole 31 (Scheme 5). The pyrrolidine was appended using indole 
addition into dimethylvinylsulfonium iodide to make the intermediate ylide which then 
attacks the aldehyde and eventually results in alkoxide displacement of dimethyl sulfide 
to form the mitomycin skeleton.
42,43
 Compound 32 is then subjected to an unusual MoO5 
oxidation which installs the C9a methoxy group and also oxidizes C9 to the ketone. 
                                                 
39
 McClure, K. F.; Benbow, J. W.; Danishefsky, S. J.; Schulte, G. K. J. Am. Chem. Soc. 1991, 113, 8185-
8186. 
40
 Benbow, J. W.; Schulte, G. K.; Danishefsky, S. J. Angew. Chem., Int. Ed. Engl. 1992, 31, 915-917. 
41
 Benbow, J. W.; McClure, K. F.; Danishefsky, S. J. J. Am. Chem. Soc. 1993, 115, 12305-12314. 
42
 Wang, Z.; Jimenez, L. S. J. Am. Chem. Soc. 1994, 116, 4977-4978. 
43
 Wang, Z.; Jimenez, L. S. J. Org. Chem. 1996, 61, 816-818. 
Figure 6. Mitomycin K  
 
 
Scheme 4. Key Transformation in Danishefsky’s Synthesis of Mitomycin K 
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Mitomycin K (5) can then be obtained by Petasis olefination and reduction of the azide to 
form the aziridine.
44
  
 
 
1.6. Other Synthetic Efforts towards Mitomycin C 
 There have been several other attempts to synthesize MMC (3).
5
 Ziegler reported 
a 5-exo-trig cyclization of an aziridinyl radical in his synthesis of desmethoxy mitomycin 
A (34, Figure 7). Aziridinyl triflate 36 was installed using SN2 displacement by indole 35 
(Scheme 6). Treatment of bromide 38, obtained from ester 37 in four steps, with 
tributyltin hydride led to the radical cyclization to form intermediate 39. Subsequent 
functional group manipulations and oxidation of 39 gave 34.
45
 
 
                                                 
44
 Wang, Z.; Jimenez, L. S. Tetrahedron Lett. 1996, 37, 6049-6052. 
45
 Ziegler, F. E.; Berlin, M. Y. Tetrahedron Lett. 1998, 39, 2455-2458. 
Scheme 5. Key Transformations in Jimenez’s Synthesis of Mitomycin K 
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 Coleman’s synthesis (Scheme 6) of desmethoxy mitomycin A (34) utilized an 
allylation reaction to make the C9-C9a bond. Treatment of azide 41 with allyl stannane 
40 gave intermediate 42. Conversion to 43 followed by 
hydrogenolysis led to Michael addition of the pyrrolidine; 
subsequent oxidation gave desmethoxy mitomycin A (34).
46
 
 Rapoport reported the synthesis of aziridinomitosene 49 
using an intramolecular Heck coupling (Scheme 7). Addition of pyrrolidine 45 to 
dibromoquinone 44 was followed by photochemical isomerization
5
 to compound 48, 
which upon treatment with palladium underwent an intramolecular Heck coupling to 
yield aziridinomitosene 49.
47
  
                                                 
46
 Coleman, R. S.; Felpin, F.-X.; Chen, W. J. Org. Chem. 2004, 69, 7309-7316. 
47
 Shaw, K. J.; Luly, J. R.; Rapoport, H. J. Org. Chem. 1985, 50, 4515-4523. 
Scheme 6. Overview of the Ziegler and Coleman Syntheses of Desmethoxymitomycin A 
 
 
Figure 7. Des-
methoxymitomycin A 
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 Vedejs constructed the quinone core using an intramolecular [3+2] cycloaddition 
between an azomethine ylide and an alkyne (Scheme 8). The azomethine ylide was 
prepared by silver triflate-mediated cyclization of oxazole 50 followed by cyanide 
addition and oxazole opening. [3+2] Cycloaddition of azomethine ylide 53 with the 
internal alkyne gave the tetracyclic core of MMC.
 48,49
 
 
  
                                                 
48
 Vedejs, E.; Klapars, A.; Naidu, B. N.; Piotrowski, D. W.; Tucci, F. C. J. Am. Chem. Soc. 2000, 122, 
5401-5402.  
49
 Bobeck, D. R.; Warner, D. L.; Vedejs, E. J. Org. Chem. 2007, 72, 8506-8518. 
Scheme 7. Rapoport’s Approach to Mitomycin C 
 
 
Scheme 8. Vedejs’s Approach to Mitomycin C 
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More recently, Vedejs synthesized an aziridinomitosane using a lactam 
cyclization (Scheme 9). A palladium-catalyzed Buchwald coupling appended lactam 56 
to the aryl ring (55). Treatment of 57 with TBSCN and catalytic KCN in the presence of 
18-crown-6 gave a 1:1 diastereomeric mixture of the intermediate cyanohydrin, which 
upon deprotonation cyclizedn onto the lactam providing 58, which was converted to an 
aziridinomitosane using TBAF to remove the cyanohydrin.
50
 
 
 
 Williams reported the synthesis of a MMK analog lacking the C9a methoxy 
moiety. The synthesis of the tetracyclic core of MMK was accomplished in one step from 
an acyclic precursor using a reductive aminocyclization reaction. As shown in Scheme 
10, the aziridine and the nitroarene were coupled to give intermediate 61, after which the 
aminocyclization precursor 62 was prepared in 5 steps. Treatment of 62 with zinc dust 
resulted in the reductive aminocyclization to give tetracyclic 63 that was then subjected 
to hydrogenolysis to remove the benzyl groups and air oxidation to give a MMK 
analog.
51
  
 
                                                 
50
 Wiedner, S. D.; Vedejs, E. Org. Lett. 2010, 12, 4030-4033. 
51
 Gubler, D. A.; Williams, R. M. Tetrahedron Lett. 2009, 50, 4265-4267. 
Scheme 9. Vedejs’s Synthesis of an Aziridinomitosane 
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Scheme 10. Key Transformations in Williams’ Approach to a MMK analog 
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Chapter 2 
 
Studies Toward the Synthesis of Mitomycin C 
 
2.1. Retrosynthetic Analysis 
 A highly convergent approach to mitomycin C (3) could be achieved by 
disconnection at the C4a-N4 and C8a-C9 junctions (Scheme 11). Intermediate 64 can be 
converted to MMC by Michael addition, ammonolysis and transformation of the alcohol 
to the carbamate. Formaldehyde addition across enamine 65 and iminium trapping with 
methanol gives 64. Intermediate 65 can be obtained by aminomercuration of alkynyl 
amine 68 and quinone trapping of the resulting enamine (67). Our prior work has 
established that regioselectivity in coupling of the enamine with quinone 66 leads to 
substitution of the methoxy group.
52
 The Brønsted acid-catalyzed aza-Darzens reaction 
will be used to quickly and efficiently install the cis-aziridine, thus allowing for a shorter 
and more convergent approach to the aminomercuration precursor.
 53,54,55
  
 
                                                 
52
 Cox, A. L.; Johnston, J. N. Org. Lett. 2001, 3, 3695-3697. 
53
 Antilla, J. C.; Wulff, W. D. J. Am. Chem. Soc. 1999, 121, 5099-5100.  
54
 Antilla, J. C.; Wulff, W. D. Angew. Chem. Int. Ed. 2000, 39, 4518-4521.  
55
 Williams, A. L.; Johnston, J. N. J. Am. Chem. Soc. 2004, 126, 1612-1613. 
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2.2. Construction of the Aziridine Subunit 
 
2.2.1. Syntheses of Aziridines 
 Natural products containing aziridines generally exhibit DNA alkylation activity. 
The mitomycins, the azinomycins and the azicemicins are examples of aziridine-
containing natural products with biological activity arising from the electrophilic nature 
of the aziridine moiety. The chemical synthesis of aziridines is an important tool for the 
syntheses of natural products and their analogs and in the design of novel bioactive 
agents.
 56
 
 
                                                 
56
 Lowden, P. A. S. In Aziridines and Epoxides in Organic Synthesis; Yudin, A. K., Ed.; Wiley-VCH: 
Weinheim, 2006, p 399-442. 
Scheme 11. Proposed Retrosynthesis of Mitomycin C 
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 The fundamental approach to aziridine synthesis involves an overall addition-
substitution sequence to an olefin or an imine (Scheme 12). The earliest preparation of 
aziridines utilized the aminoalcohol as a precursor. Intramolecular substitution of the 
alcohol (after conversion to the mesylate or halide) by the amine results in the formation 
of the aziridine. Key developments in this approach include the improved syntheses of 
aminoalcohols using dihydroxylation, aminohydroxylation and epoxidation (Scheme 12). 
For example, Sharpless epoxidation has allowed the preparation of enantiomerically pure 
epoxides. Azide opening of the epoxide, reduction and phosphine-mediated ring closure 
Scheme 12. Strategies for Aziridine Synthesis 
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(Blum-Ittah aziridine synthesis) produces the enantiomerically pure aziridine (Scheme 
13).
57,58
 
 
 
 A more convergent aziridine synthesis is achieved by carbene, ylide and enolate 
addition to imines (Scheme 12). Addition of a carbene, generated from ethyl 
diazoacetate, to imines was reported as early as 1972.
59
 The first catalytic asymmetric 
aziridine synthesis via a carbene was reported by Jacobsen (Scheme 14).
60
 Wulff later 
reported the asymmetric synthesis of cis-aziridines from benzhydryl imines and ethyl 
diazoacetate with chiral boron Lewis acids.
53
 
 
                                                 
57
 Sweeney, J. B. Chem. Soc. Rev. 2002, 31, 247-258. 
58
 Ittah, Y.; Sasson, Y.; Shahak, I.; Tsaroom, S.; Blum, J. J. Org. Chem. 1978, 43, 4271-4273. 
59
 Baret, P.; Buffet, H.; Pierre, J. L. Bull. Soc. Chim. Fr. 1972, 2493-2501. 
60
 Hansen, K. B.; Finney, N. S.; Jacobsen, E. N. Angew. Chem., Int. Ed. Engl. 1995, 34, 676-678. 
Scheme 13. Phosphine-Mediated Ring Closure of Azidoalcohols 
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 Aggarwal reported the first catalytic asymmetric ylide aziridinations. The chiral 
sulfonium ylide was generated in situ from the corresponding sulfide and TMS-propargyl 
bromide, which then added to the N-tosylimine to yield the optically active aziridine 
(Scheme 14).
61
 α-Bromoenolate addition to chiral sulfinimines is another effective 
method to prepare chiral aziridines (Scheme 14).
62
 The Gabriel-Cromwell reaction 
involves a Michael addition of an amine to an α-bromoacrylate (Scheme 15). 
Intramolecular substitution of the bromide by the amine forms the aziridine.
63
 
 
                                                 
61
 Li, A.-H.; Dai, L.-X.; Aggarwal, V. K. Chem. Rev. 1997, 97, 2341-2372. 
62
 Davis, F. A.; Liu, H.; Zhou, P.; Fang, T.; Reddy, G. V.; Zhang, Y. J. Org. Chem. 1999, 64, 7559-7567. 
63
 Filigheddu, S. N.; Taddei, M. Tetrahedron Lett. 1998, 39, 3857-3860. 
Scheme 14. Carbene, Ylide and Enolate Additions to Imines 
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 Azide addition to olefins is another convergent synthetic strategy to prepare 
aziridines, and was used in the Fukuyama and Danishefsky syntheses of the 
mitomycins.
37,40,41
 The azide substituent dictates the reaction pathway; non-acyl azides 
generally proceed via the triazoline that then eliminates N2 to form the aziridine, while 
acyl azides generate nitrenes that add to the olefin (Scheme 12). Nitrenes were 
traditionally generated using thermal and photochemical decomposition, but this resulted 
in a mixture of singlet and triplet nitrenes. Herein lay the drawback of nitrene addition to 
olefins: singlet nitrenes stereospecifically added to olefins while triplet nitrenes did not.
57
 
Rees performed the in situ generation of nitrenes by oxidation of hydrazine derivatives; 
these reactions showed improved stereoselectivity and implied the generation of singlet 
nitrenes under the reaction conditions (Scheme 16).
64
 
 
 
2.2.2. Brønsted Acid-Catalyzed Synthesis of Aziridines 
 The Brønsted acid-catalyzed aza-Darzens reaction with ethyl diazoacetate as the 
latent enolate was developed as an extension of the Lewis acid-catalyzed version.
53
 Ethyl 
                                                 
64
 Anderson, D. J.; Gilchrist, T. L.; Horwell, D. C.; Rees, C. W. J. Chem. Soc. C 1970, 576-582. 
Scheme 15. Gabriel-Cromwell Reaction 
 
 
Scheme 16. Nitrene Addition to Olefins 
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diazoacetate was added to N-alkyl imines in the presence of catalytic Brønsted acid, 
despite the stoichiometric formation of basic N-alkyl amine. 
 A Brønsted acid screen with glyoxylate imine 70 and equimolar ethyl 
diazoacetate afforded cis-aziridine 71 in yields up to 74% (Scheme 17), indicating 
turnover of the Brønsted acid in spite of basic product formation. Trifluoroacetic acid, 
camphor sulfonic acid, hydrochloric acid and triflic acid were promising candidates, and 
decreasing pKa of the acid was observed to increase reaction rate. As a result, triflic acid 
was used as the Brønsted acid of choice. The solvent did not affect the reaction yield but 
nonpolar solvents slowed the reaction (e.g. toluene, dichloromethane).
54
 
 
 
 The scope of the reaction is represented in Scheme 18. Electron-poor imines like 
the glyoxylate imines (entries 1 and 2) provided excellent cis selectivity and yields; alkyl 
imines (entries 4 and 7) gave good cis selectivity. Modest selectivity was observed for the 
tert-butyl (entry 5) and alkynyl groups (entry 8).
54, 65
  
 
                                                 
65
 Williams, A. L. Ph.D. Dissertation, Department of Chemistry, Indiana University, October 2004 
Scheme 17. Brønsted Acid Screen of the Aza-Darzens Reaction of Ethyl Diazoacetate and an α-Imino 
ester
54
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2.2.3. Synthesis of the Aziridine Subunit 
 The cis-aziridine required for mitomycin C is installed convergently using the 
Brønsted acid-catalyzed aza-Darzens reaction.
54
 The imine substrate (72) for this reaction 
is prepared in three steps from commercially available propargyl alcohol. As outlined in 
Scheme 19, alkyne protection of propargyl alcohol,
66
 oxidation
67
 and condensation of the 
resulting aldehyde with diphenyl methylamine afforded imine 72 (E:Z ratio 1:0.7). The 
imine E:Z ratio is dependent on the alkyne protecting group and ranges from 1:0.7 
(trimethylsilyl) to exclusively E geometry (triphenylsilyl).
68,69
 The Brønsted acid-
catalyzed aza-Darzens reaction of 72 with ethyl diazoacetate yielded cis-aziridine 73 in 
39-53% yield (70% for triphenylsilyl cis-aziridine).
65,69
 Saponification of the ethyl ester 
moiety of 73 and subsequent carbodiimide coupling with diphenyl methylamine gives 
                                                 
66
 Davison, E. C.; Forbes, I. T.; Holmes, A. B.; Warner, J. A. Tetrahedron 1996, 52, 11601-11624. 
67
 Harris, N. J.; Gajewski, J. J. J. Am. Chem. Soc. 1994, 116, 6121-6129. 
68
 Srinivasan, J. M. Ph.D. Dissertation, Department of Chemistry, Indiana University, December 2008 
69
 Srinivasan, J. M.; Mathew, P. A.; Williams, A. L.; Huffman, J. C.; Johnston, J. N. Chem. Commun. 2011, 
47, 3975-3977. 
Scheme 18. Variation of the Imine Substituent in the Brønsted Acid Catalyzed Aza-Darzens Reaction
65
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amide 74. Reduction of the amide with Red-Al afforded the requisite coupling substrate 
68.
69
  
 
 
2.3. Construction of the Quinone Subunit 
 Nearly 200 of the naturally occurring quinones are potentially reductive alkylating 
agents because they are precursors to reactive quinone methides. Natural products 
containing these motifs are viable chemotherapeutic agents, as their bioreductive 
activation makes them significantly more toxic towards hypoxic tumor cells than normal 
cells or oxygen-rich tumor cells.
 70
 Mitomycin C is one such example, and as a result, has 
been the target of many synthetic chemists. 
 For the synthesis of MMC, the requisite quinone subunit 66 was prepared 
efficiently on large scale from commercially available 2,6-dimethoxytoluene (Scheme 
20). Friedel-Crafts acylation followed by Baeyer-Villiger oxidation gave aryl acetate 77. 
Saponification to the phenol and oxidation delivered quinone 78.
71
 Using Rapoport’s 
procedure, dibromoquinone 44 was obtained by reduction to the hydroquinone, followed 
                                                 
70
 Moore, H. W.; Czerniak, R. Med. Res. Rev. 1981, 1, 249-280. 
71
 Hans-Joachim Knölker, W. F., Kethiri R. Reddy Synthesis 2002, 557-564. 
Scheme 19. Preparation of Aziridine 68 
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by bromination and oxidation.
72
 New methods to shorten the synthetic sequence by direct 
oxidation of 2,6-dimethoxytoluene to the quinone (78) using nitric acid and hydrogen 
peroxide in glacial acetic acid or hydrogen peroxide in formic acid were successful but 
lower yielding,
73,74
 while the direct oxidation with CAN did not yield any of the desired 
quinone. Similarly, bromination of saponified 77 would shorten the synthesis of 44 by 
two steps, however, the reaction resulted in a mixture of mono- and dibromination 
products.
75
 The synthetic route in Scheme 20 was chosen for its higher yields and 
convenience (no purification required). 
 
 
 The regioselectivity of the prepared quinones was investigated in order to 
establish appropriate substitution for the MMC core. Rapoport performed pyrrolidine 
additions to unsubstituted quinone 78 and dibromoquinone 44 (Scheme 21). Both 
quinones favored addition at C4a.
72
 Therefore addition of a nitrogen nucleophile would 
                                                 
72
 Luly, J. R.; Rapoport, H. J. Org. Chem. 1981, 46, 2745-2752. 
73
 González, R. R.; Gambarotti, C.; Liguori, L.; Bjørsvik, H.-R. J. Org. Chem. 2006, 71, 1703-1706. 
74
 Herzon, S. B.; Calandra, N. A.; King, S. M. Angew. Chem. Int. Ed. 2011, 50, 8863-8866. 
75
 Fujisaki, S.; Eguchi, H.; Omura, A.; Okamoto, A.; Nishida, A. Bull. Chem. Soc. Jpn. 1993, 66, 1576-
1579. 
Scheme 20. Preparation of Dibromoquinone 44 
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forge the desired C4a-N4 bond. However, since our proposed route to MMC utilized an 
enamine addition, C4a addition was undesirable. This was confirmed with stannyl 
enamine 79 addition to dibromoquinone 44, that furnished the undesired regioisomer for 
MMC synthesis (Scheme 21).
52
 
 
 
 In order to electronically differentiate C4a and C8a, the vicinal element effect was 
investigated. The vicinal element effect predicts that the substitution will occur through 
the pathway that best stabilizes the negative charge in the transition state.
76
 However, 
methoxide substitution of the dibromoquinone showed a solvent-induced reversal of 
regioselectivity; desired 66 was favored in a 2:1 ratio with potassium methoxide in 
acetonitrile (Scheme 22) while undesired 80 was favored in a 2:1 ratio with magnesium 
methoxide in methanol.
52
 
 
                                                 
76
 Rappoport, Z. In Adv. Phys. Org. Chem.; Gold, V., Ed.; Academic Press: 1969; Vol. 7, p 1-114. 
Scheme 21. Regioselectivity of Quinone Additions 
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 Stannyl enamine 79 addition to the bromomethoxyquinones 66 and 80 resulted in 
selective methoxide substitution, giving desired 81 and undesired 82 respectively 
(Scheme 22).
52
 In these additions, the bromine is postulated to play a role in stabilizing 
the negative charge. This would indicate that the vicinal effect is operational in the 
regioselectivity of the enamine substitution. 
 
2.4. Enamine-Quinone Coupling: Tandem Formation of N4-C9a, C9-C8a Bonds 
 The aminomercuration of terminal acetylenes with catalytic mercury(II) chloride 
to give imines or enamines was first reported by Barluenga in the 1980s (Scheme 
23).
77,78,79
 An intramolecular version of this reaction with alkynyl amine 68 (Scheme 25) 
should give the requisite enamine, which upon electrophilic trapping of quinone 66, 
would provide an advanced intermediate towards MMC with a high level of 
convergency. 
 
                                                 
77
 Barluenga, J.; Aznar, F.; Liz, R.; Rodes, R. J. Chem. Soc., Perkin Trans. 1 1980, 2732-2737.  
78
 Barluenga, J. A., F.; Liz, R. Synthesis 1984, 304-308. 
79
 Barluenga, J.; Aznar, F.; Liz, R.; Cabal, M.-P. Synthesis 1986, 960-962. 
Scheme 22. Examination of the Vicinal Effect 
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 An initial investigation into the feasibility of an intramolecular aminomercuration 
used the α–methylbenzyl-protected amine 83 and quinone 66 (Scheme 24). Gratifyingly, 
treatment with HgCl2 and in situ trapping of quinone 66 furnished intermediate 84.
80
 
Consistent with earlier observations, the enamine added to C8a of the quinone and the 
resulting enamine was now ready for addition of the last carbon required for MMC before 
Michael addition into the quinone. The highly reactive nature of this intermediate 
complicated efforts to install C10;
81
 in order to better control the reactivity of the coupled 
intermediate, the alkyl protecting group on the amine was changed to the diphenylmethyl 
group (DPM). 
 
 
 Treatment of diphenylmethyl-protected amine 68 with HgCl2 followed by 
quinone 66 and NaBH4 was expected to give hydroquinone 86 (Scheme 25). 
Spectroscopic data for the isolated product was unlike that of the α-methylbenzyl 
protected intermediate 84 but still corresponded to the expected hydroquinone product 
                                                 
80
 Williams, A. L.; Srinivasan, J. M.; Johnston, J. N. Org. Lett. 2006, 8, 6047-6049. 
81
 Approximate half-life of coupled product 79 is 1.5 days at −15 °C. Rapid decomposition (on the order of 
minutes) was observed in chlorinated solvents. 
Scheme 23. Aminomercuration of Terminal Acetylenes 
 
 
Scheme 24. Aminomercuration of Amine 83 
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86. In order to obtain additional data to elucidate the structure of compound 86, it was 
treated with benzoyl chloride and triethylamine to esterify both phenolic hydroxyls. A 
single phenolic hydroxyl group was esterified despite varying reaction conditions. 
Deprotection of the pyrrolidine protecting group by oxidative cleavage was 
unsuccessful.
69
  
 
 
 Since pyrrolidine deprotection proved to be difficult at this stage and the next step 
was to install C10, the enamine nucleophilicity was assessed using N-chlorosuccinimide. 
The chlorinated product was crystalline, and an X-ray structure was obtained (Scheme 
25). This revealed that the bromine on the hydroquinone ring had been replaced by a 
hydrogen, and one phenolic hydroxyl group had formed a seven-membered ring with the 
pyrrolidine diphenylmethyl group. By retrospective analysis, the coupling reaction had 
resulted in an oxidative ketalization to form N,O-ketal 88, thus explaining the previously 
observed reactivity (mono-benzoylation).
69
  
Scheme 25. Aminomercuration of DPM-Amine 68 
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 This unusual transformation required two reducing equivalents during the 
reaction. The concomitant oxidation of the pyrrolidine diphenylmethyl group suggested 
an intramolecular source of one equivalent of hydride. This would also explain why the 
α-methylbenzyl protected pyrrolidine, which will not donate a hydride as readily, did not 
undergo ketalization (Scheme 24).
69
  
 The intramolecular hydride transfer hypothesis was investigated using a 
deuterium labeling experiment (Scheme 26). Deuterated alkynyl amine d-68 was 
subjected to the standard reaction conditions. The coupled N,O-ketal showed an 88% 
deuterium incorporation; this verifies that one of the two reducing equivalents results 
from the intramolecular transfer of the diphenylmethyl methine. The second hydride is 
hypothesized to come from triethylamine or the solvent.
69
  
 
 
 Additionally, if the methine of the diphenylmethyl group were to be removed by 
using an α,α-diphenylethyl group, aminomercuration should give the nonketalized 
coupled product, analogous to the α–methylbenzyl case. Unfortunately, the standard 
reaction conditions produced the methyl ketone (arising from oxymercuration) with no 
quinone incorporation.
68
 
Scheme 26. Deuterium Labeling Experiment 
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 With this data in hand, the mechanism of formation of N,O-ketal 88 can be 
proposed (Scheme 27). The initial aminomercuration of alkynyl amine 68 and subsequent 
enamine addition to quinone 66 would form coupled intermediate 65. An E/Z 
isomerization would bring the pyrrolidine in close proximity for the 1,6-hydride shift of 
the diphenylmethyl methine, resulting in elimination of the bromide and subsequent 
cyclization of the quinone oxygen onto the iminium ion 90. A second hydride addition 
and tautomerization would then give observed product 88.
69
  
 
 
 The unexpected but powerful transformation from 68 and 66 to 88, in essence a 
one-pot aminomercuration-quinone trapping-oxidative ketalization, delivers a useful 
advanced intermediate containing all but one of the required carbons for mitomycin C. 
Scheme 27. Proposed Mechanism for Oxidative Ketalization 
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The oxidative ketalization provides differential protection for both phenolic hydroxyls 
and the pyrrolidine and aziridine nitrogens while maintaining the nucleophilicity of the 
enamine required to install C10, as evidenced by the chloroenamine formation. 
 At this point, the key accomplishments by Amie Williams and Jayasree 
Srinivasan were: 
o preparation of an aziridinyl alkynyl amine using the Brønsted acid catalyzed aza-
Darzens reaction  
o investigation of quinone regioselectivity  
o construction of an aziridine-containing pyrrolidine (N4-C9a bond) using 
aminomercuration and in situ regioselective coupling with the quinone (C9-C8a 
bond) to form an N,O-ketal lacking only C10 of the mitomycin skeleton  
o mechanistic studies of the oxidative ketalization to form the N,O-ketal  
On the basis of these benchmarks, this dissertation highlights the following 
achievements: 
o further investigations into N,O-ketal reactivity with carbon electrophiles  
o successful installation of C10 using the N,O-ketal intermediate  
o successful installation of C10 prior to the coupling of the alkynyl amine and the 
quinone using a methyl-substituted alkyne  
o preparation of an aziridinyl pyrrolidine intermediate containing a functionalized 
C10  
o construction of an aminoquinone (N4-C4a bond)  
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2.5. Installation of C10 on N,O-ketal Enamine 
 The coupling of quinone 66 and amine 68 resulted in the formation of advanced 
intermediate 88 that lacked only the carbamoyl carbon (C10) to complete the mitomycin 
skeleton. Initially, a simultaneous installation of C10 and the C9a methoxy group of 
MMC was envisioned by epoxidation and subsequent nucleophilic ring opening (Scheme 
28). Unfortunately, this led to an inseparable mixture of two compounds that lacked the 
epoxide. The major product, tentatively assigned as ketone 94, is postulated to arise from 
epoxide opening by the pyrrolidine nitrogen, followed by hydrolysis of the N,O-ketal and 
oxidation to the ketone. Other oxidation attempts resulted in the isolation of 
benzophenone but decomposition of the rest of the molecule.
68
 
 
 
 It seemed likely that the electron-rich hydroquinone ring and/or the aziridine 
nitrogen were interfering under the oxidative conditions. The oxidation of the 
hydroquinone and the concomitant N,O-ketal opening would give a product similar to 
highly reactive α-methylbenzyl-protected 84 (as discussed earlier) that rapidly 
decomposes. Therefore, an alternative strategy would harness intermediate 92’s electron-
rich nature by electrophilic enamine trapping, while retaining the N,O-ketal to stabilize 
these highly advanced intermediates. 
Scheme 28. Epoxidation Attempt on Enamine 92 
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 Ideally, enamine 92 would be trapped with a one-carbon electrophile. Due to the 
limited availability of electrophilic one-carbon reagents, we also considered other 
suitable electrophiles, that could then be modified – either before installation (by 
designing a one-carbon analog) or after installation (by removing extra carbons via 
ozonolysis, decarboxylation etc.). 
 Accordingly, compound 92 was treated with a series of one-carbon electrophiles 
(Scheme 29). Bromonitromethane and carbonyldiimidazole (CDI) gave no reaction; 
treatment with Eschenmoser’s salt,68 formaldehyde (with and without Lewis-acids, e.g. 
TiCl4, BF3•OEt2), paraformaldehyde and ethyl chloroformate led to no recognizable 
products.
82,83
 In most cases, benzophenone was observed with decomposition of the rest 
of the compound as observed previously. 
 
 
 Formylation of 92 was also attempted. Riemer-Tiemann conditions with sodium 
hydroxide in chloroform at reflux gave no reaction.
84
 Treatment with dichloromethyl 
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 (CH2O)n, Mg(OMe)2: Wang, Y.; Wang, M.; Wang, L.; Wang, Y.; Wang, X.; Sun, L. Appl. Organomet. 
Chem. 2011, 25, 325-330.  
83
 Mg(OMe)2 preparation: (a) Wuttke, S.; Lehmann, A.; Scholz, G.; Feist, M.; Dimitrov, A.; Troyanov, S. 
I.; Kemnitz, E. Dalton Trans. 2009, 4729-4734. (b) Brown, A. C.; Carpino, L. A. J. Org. Chem. 1985, 50, 
1749-1750. 
84
 Sharma, H.; Patil, S.; Sanchez, T. W.; Neamati, N.; Schinazi, R. F.; Buolamwini, J. K. Bioorg. Med. 
Chem. 2011, 19, 2030-2045. 
Scheme 29. One-Carbon Homologation Attempts 
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methylether in the presence of titanium tetrachloride resulted in decomposition.
85
 The 
Duff formylation reaction with hexamethylenetetramine in neat trifluoroacetic acid 
resulted in decomposition. Modification of the Duff reaction conditions using acetic acid, 
formic acid and aqueous hydrochloric acid did not improve the reaction outcome.
86,87
 
Performing the Duff reaction with TFA at lower temperatures revealed consumption of 
starting material to a compound that did not have aziridine protons, therefore it is likely 
that the aziridine opened with no other observable changes by 
1
H NMR. 
A variety of other electrophiles were also examined (Scheme 30). Phenyl 
isocyanate gave no reaction. An enamine-aldol reaction with ethyl glyoxylate led to 
decomposition (as did treatment with the methyl acetal of ethyl glyoxylate and 
diisopropylethylamine). Treatment of 92 with valeraldehyde resulted in decomposition 
due to acidic reaction conditions.
88
 A one-electron oxidative allylation was investigated 
using allyltrimethylsilane and ceric ammonium nitrate which resulted in immediate 
decomposition; allylation with allyl bromide led to no conversion of starting material. A 
Diels-Alder reaction with nitrostyrene in refluxing toluene also gave no reaction.
89
 
Nitromethylation with tributyltin hydride gave no reaction, while manganese(III) 
acetate
90
 resulted in decomposition. Cyclopropanation conditions also resulted in 
immediate decomposition of starting material.
91
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 It can be concluded that oxidation and direct carbon homologation of the enamine 
are difficult due to the competing reactive functionalities present in this advanced 
intermediate. Previous success of enamine halogenation using N-chlorosuccinimide (87) 
led to the next logical step, i.e. to introduce a carbon via the manipulation of C10 halides. 
 
2.6. Installation of C10 on Bromoenamine 
 
2.6.1. Preparation of the Bromoenamine 
 A C-X bond (X = halide) can be transformed into a C-C bond using a variety of 
conditions, such as lithium-halogen exchange, Grignard formation and cross-coupling 
reactions. We decided to use lithium-halogen exchange to install C10. In this regard, 
chlorination of enamine 92 using N-chlorosuccinimide had been achieved (87, Scheme 
25) even though direct addition of carbon electrophiles to the enamine had been 
unsuccessful. Since bromides are more prevalent in metalation chemistry than chlorides, 
we sought to prepare bromoenamine 95.  
Scheme 30. Enamine Reactivity Screen 
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 Treatment of enamine 92 with N-bromosuccinimide (NBS) resulted in clean 
conversion to desired bromoenamine 95 (Scheme 31).
68
 Additionally, we considered 
trapping the intermediate iminium ion (96) with an oxygen nucleophile to install the C9a 
methoxy group. Various nucleophiles and brominating agents did not succeed in trapping 
the iminium ion, but formed bromoenamine 95 in varying yields with some 
decomposition (i.e. benzophenone formation). Additionally, sodium cyanide was added 
to a standard NBS reaction to see if an intermediate bromonium ion could be trapped; 
however, rapid decomposition was observed. 
 
 
In conclusion, bromoenamine 95 was prepared for C10 homologation. Iminium 
ion 96 proved to be a fleeting intermediate and could not be captured to install the C9a 
methoxy group. 
2.6.2. Lithium-Halogen Exchange on the Benzoyl-Protected Phenol 
 To investigate the formation of the C10-Li bond, bromoenamine 95 was subjected 
to lithium-halogen exchange followed by deuterium oxide addition. 
1
H NMR revealed 
Scheme 31. Bromoenamine Formation and Iminium Trapping 
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successful enamine deuteration accompanied by phenol deprotection (Scheme 32). The 
observed protonation of the enamine was presumably due to adventitious moisture 
present in the reaction mixture. 
 
 
 The benzoyl group was clearly incompatible with butyllithium; it had been 
initially chosen to withstand oxidation. Since its deprotection was competitive with 
lithium-halogen exchange, an alternate protecting group was required. However, the 
extreme selectivity of enamine reactivity had already been realized with the success of 
halogenation, and the failure in alkylation and acylation. In order to ascertain the viability 
of adding a carbon electrophile, bromoenamine 95 was treated with 4.5 equivalents 
n
BuLi 
and excess methyl chloroformate (Scheme 33). 
 
Scheme 32. Deuterium Addition to Bromoenamine 95 
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 Desired vinylogous carbamate 97 with the carbonate-protected phenol was 
obtained in a 33% yield (Scheme 33). 2D NMR analysis confirmed the incorporation of 
the methyl ester at C9. In addition to methyl ester 97, carbonate-protected bromoenamine 
98 (16%) was formed. This suggested that the lithium-halogen exchange was slower than 
the benzoyl deprotection, perhaps due to steric congestion. Protonated carbonate 99 
(12%), starting material 95 (5%) and protonated phenol 88 (trace by 
1
H NMR) were also 
observed. Due to the competitive formation of side products, reproducibility of this 
reaction was low. In an attempt to increase reproducibility, different solvents were used 
to control the reactivity of butyllithium (toluene, THF-cyclohexane), but neither of these 
conditions produced any reaction.
92
 The Turbo Grignard developed by Knochel 
(
i
PrMgCl•LiCl) produced inconsistent results (no reaction or decomposition).93,94 These 
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Scheme 33. Methyl Chloroformate Addition to Bromoenamine 
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experiments suggest that butyl lithium in THF provided the optimal reactivity for this 
system. 
 Installation of C10 was thus accomplished; vinylogous carbamate 97 contains all 
requisite carbons for MMC. Having confirmed the viability of the bromoenamine as an 
intermediate for C10 installation, there remains the need for a suitable phenol protecting 
group. 
2.6.3. Lithium-Halogen Exchange on Other Protected Phenols 
 The criteria for an appropriate phenol protecting group were stability to strong 
bases, such as butyllithium, and to reducing agents (for future vinylogous carbamate 
reduction), and deprotection conditions compatible with the aziridine. The p-
methoxybenzyl group (PMB) fulfilled these criteria with the attractive possibility of 
oxidative cleavage of the N,O-ketal with concomitant oxidation of the hydroquinone.  
 Amine 68 was coupled with quinone 66, followed by phenol protection and 
bromination (Scheme 34). The PMB-enamine 100 and PMB-bromoenamine 101 were 
more reactive than their benzoyl counterparts; enamine 100 and bromoenamine 101 
decomposed on gentle heating, and bromination of PMB-enamine 100 with NBS was 
significantly faster than on benzoyl-enamine 92 (3-5 min vs. 15-30 min). 
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 Bromoenamine 101 was treated with butyllithium and methyl chloroformate 
(Scheme 34). Mass spectral data of the resulting product confirmed methyl ester 
incorporation but the expected vinylogous ester 102 had a carbonyl peak at 154.9 ppm by 
13
C NMR (unlike benzoyl-protected vinylogous ester 97: 170.3 ppm) and a C=O stretch 
at 1769 cm
-1
 by IR (unlike benzoyl-protected vinylogous ester 97: 1701 cm
-1
). 2D NMR 
experiments were not conclusive but indicated that the aziridine and the pyrrolidine were 
intact, as was the hydroquinone. Treatment with lithium aluminum hydride of the 
expected vinylogous carbamate 102 should form the C10-methylene alcohol. However, 
1
H NMR and DEPT-135 lacked a CH2 required for this structure. Mass spectrometry 
confirmed the complete removal of the methyl ester unit from the expected vinylogous 
carbamate 102 and IR indicated an NH/OH (broad absorption at 3509 cm
-1
). This 
suggested N-acylation with methyl chloroformate. The lithium-halogen exchange product 
is tentatively assigned as 103; the 
13
C NMR and IR data correspond better with a 
carbamate, and the experimental data obtained from the reduction of carbamate 103 with 
lithium aluminum hydride correspond well with compound 104. 
Scheme 34. Metalation of the PMB-Bromoenamine 
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 To prevent N-acylation, the lithiated enamine was treated with Mander’s reagent 
(CNCO2Me) but only enamine protonation (100) was observed. This suggested that the 
reaction pathway took an unexpected turn after the lithium-halogen exchange. The 
proposed mechanism for this transformation is shown in Scheme 35. After lithiation, 
enamine 106 could be in equilibrium with alkyne 107. Acylation of the nitrogen could 
then lead to N,O-ketal opening, and subsequent nitrogen attack on the alkyne and 
cyclization of the alkyne on the oxonium would then give carbamate 103. 
 
 
 There clearly exists a striking relation between the phenol protecting group and 
lithiated enamine addition. This relationship is presumably electronic in nature due to the 
increased reactivity of the PMB-intermediates as compared to the benzoyl protected 
intermediates, as previously noted. If the electronic nature of the protecting group 
Scheme 35. Proposed Mechanism for 103 Formation 
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determines the reaction pathway, then the desired metalation pathway can be achieved 
with an electron-withdrawing protecting group. Unfortunately, most electron-
withdrawing groups are sensitive to butyllithium, however, the exception is a non-
traditional protecting group for phenols i.e. the tosyl group. 
 Tosyl-bromoenamine 111 was prepared and subjected to standard lithium-halogen 
exchange conditions (Scheme 36). A complex reaction mixture was observed by 
1
H NMR and showed some starting material, some protonated enamine and a trace 
amount of product. 
 
 
 In conclusion, lithium-halogen exchange occurred readily on bromoenamines 95 
and 101; however, the subsequent pathway was highly dependent on the phenol 
protecting group. The benzoyl group gave desired C-acylation accompanied by undesired 
phenol deprotection, while the PMB group gave undesired N-acylation. Milder metalating 
conditions might be an alternative solution to C10 installation without phenol 
deprotection. 
2.6.4. Other Metal-Mediated Attempts to Install C10 
 Palladium cross-couplings were explored in the hope of finding a mild non-
nucleophilic metalating reagent (Scheme 37). Heck reaction of bromoenamine 95 gave a 
Scheme 36. Metalation of Tosyl Bromoenamine 111 
 
 
46 
 
complex mixture with no desired vinyl peaks by 
1
H NMR. Cyanide substitution on 
bromoenamine 95 resulted in mostly starting material and no desired nitrile product.
95
 
Additionally, Grignard formation with magnesium in THF followed by methyl 
chloroformate addition, gave no conversion of bromoenamine 95. 
 
 
 The bromide position of bromoenamine 95 was previously observed to react 
slower than the benzoyl group with butyllithium. Steric congestion at the bromoenamine 
could be the cause, and therefore, might explain the lower reactivity with larger metals 
(like palladium) endowed with bulky ligands.  
 Our endeavor to introduce C10 on advanced intermediate 95 was successful under 
lithium-halogen exchange conditions, and afforded carbamate 97, a promising 
intermediate towards the synthesis of MMC. While efforts to side-step phenol 
deprotection were not fruitful, the phenol carbonate (97) can be selectively manipulated, 
if necessary, to distinguish between the phenol and C10-alcohol. 
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Scheme 37. Palladium Cross-Coupling Attempts 
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2.7. Installation of the C10-Methyl Prior to Coupling 
 Installation of C10 can be simplified by its introduction prior to the coupling, 
thereby reducing manipulations on the highly functionalized N,O-ketal 88. Alkyne 
substituent effects on aminomercuration had not been previously investigated; hence the 
steric effects were unknown. Previous work with vinylogous amide 113, prepared from 
terminal alkyne 68, had established that an electron-withdrawing carbonyl group at the 
enamine position inhibited quinone addition.
65
 In order to investigate the feasibility of 
introducing C10 via the alkyne prior to coupling, the methyl group was chosen, on 
account of its minimal steric and electronic effects. Additionally, allylic oxidation at the 
methyl position of methylated N,O-ketal 117 (Scheme 39) would provide the requisite 
alcohol for MMC. 
 
 
2.7.1. Preparation and Coupling of the Methyl-Substituted Alkyne 
 Methylation of terminal alkyne 68 was accomplished in 71% yield (Scheme 39). 
Standard coupling conditions with mercury(II) chloride, triethylamine and quinone 66 
afforded a product that was spectroscopically different from expected N,O-ketal 117. 
1
H NMR revealed a methyl doublet instead of the expected singlet, and mass 
spectrometry indicated retention of bromine. The aziridine and the pyrrolidine were 
intact, as was the hydroquinone. 2D NMR analysis suggested (racemic) spiroketal 116 to 
Scheme 38. Vinylogous Amide Addition to Quinone 66 
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be the proposed product with the pyrrolidine nitrogen and the C10 methyl anti to each 
other. 
 
 
 It was evident that methyl substitution of the alkyne had prevented the oxidative 
ketalization required to form the expected product 117, presumably to accommodate the 
increased steric crowding at the alkyne terminus. Spiroketal 116 is hypothesized to form 
by quinone carbonyl addition to intermediate iminium ion 119, following enamine 
addition into the quinone (Scheme 40). Demercuration and hydride addition to resulting 
quinone methide (hydride from triethylamine or the solvent) would give observed 
product 116. 
 
Scheme 39. Coupling of Methyl-Substituted Alkyne with Quinone 66 
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 Spiroketal 116, though unexpected, established the feasibility of introducing C10 
prior to the coupling. It contains all carbons required for MMC at the correct oxidation 
state, with the exception of C10, which needs to be oxidized to the alcohol. Deprotection, 
N,O-ketal opening and subsequent Michael addition into the quinone would give MMC. 
2.7.2. Deprotection of the Spiroketal 
 Deprotection of the pyrrolidine would ready spiroketal 116 for the subsequent 
transformations required to prepare MMC. If the aziridine deprotected faster or 
competitively, we would have access to the MMC core via Fukuyama’s isomitomycin 
approach.
36,37
 To this end, oxidative and reductive deprotection conditions were 
attempted for the pyrrolidine DPM group. Acylating deprotection conditions were 
attempted for the aziridine DPM group. 
 
Scheme 40. Proposed Mechanism for Spiroketal 116 Formation 
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 Standard oxidative deprotecting conditions with DDQ and CAN (Table 1) led to 
quinone oxidation but no deprotection. Additionally, a methyl singlet was observed by 
1
H NMR suggesting formation of the enamine. Increasing the equivalents of DDQ to 
force deprotection led to rapid decomposition. Less common oxidizing agents gave 
similar results or no reaction. Further spectroscopic analysis was not undertaken, but 
preliminary data from mass spectrometry, indicating bromide loss, and 
1
H NMR 
suggested that quinone oxidation was followed by enamine formation (Scheme 41) and 
Michael addition of water (or other nucleophiles, if present) into the quinone. 
 
Table 1. DPM Deprotection Attempts 
 
 
Scheme 41. Proposed Pathway under Oxidative Cleavage Conditions 
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 Due to the lack of deprotection under oxidative conditions, attention was turned to 
reductive methods to remove the DPM group (Table 1). Hydrogenation, transfer 
hydrogenation and mild reducing agents resulted in complex reaction mixtures that 
mostly indicated decomposition of the aziridine. Purification of these complex mixtures 
performed on small scale was unsuccessful in these cases, but mass spectrometry of some 
impure products showed bromide loss but no removal of the DPM groups. 
 Deprotection by acylation of the aziridine and subsequent nucleophilic removal of 
the DPM group afforded reaction mixtures with no aziridine (Table 1). Using NIS, 
aziridine N-iodination is postulated to occur, followed by rapid ring opening by the 
phenol (Scheme 42). No reaction was observed with methyl chloroformate (Table 1).  
 
 
 To summarize, the installation of C10 prior to the coupling reaction was 
accomplished, despite concerns of steric and electronic effects on aminomercuration and 
the subsequent quinone addition. Unexpected spiroketal 116 is a potential intermediate to 
MMC analog. Deprotection of spiroketal 116 has not been realized as yet due to 
competing reactive functionalities that result in complex mixtures; a possible solution to 
obtain selective deprotection are phenol protection or N,O-ketal opening before 
deprotection. 
Scheme 42. Proposed Pathway of Acylating Deprotection Conditions 
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2.8. Installation of a Functionalized C10 Prior to Coupling 
 
 The success with the methyl(C10)-alkyne 115 validated C10 introduction prior to 
the coupling. MMC requires C10 at the alcohol oxidation state. However, the unforeseen 
reaction pathway with alkyne 115 implied that allylic oxidation to form the C10-alcohol 
was no longer possible (Scheme 43). To this end, a functionalized C10-alkynyl amine 
was sought. A cyclization product similar to the spiroketal (116) would be expected due 
to the steric similarity. The ideal choice would be a protected alcohol, and previous 
experience with vinylogous amide 113 (Scheme 38) negated the use of electron-
withdrawing alcohol precursors, i.e. carbonyl, carboxyl and nitro groups. Therefore, a 
benzyl-protected alcohol was chosen because the electronics would not be unfavorable 
and deprotection using reductive methods should be compatible with more advanced 
intermediates. 
 
Scheme 43. Aminomercuration-Quinone Coupling Products Based on Alkyne Substitution 
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2.8.1. Preparation of the Functionalized C10 Aziridine 
 Introducing the methylene alcohol unit on alkyne 68 via deprotonation and 
addition to formaldehyde was unsuccessful (Scheme 44). Other electrophiles and bases 
(ethylmagnesium bromide) were unsuccessful as well. As a result, the methylene alcohol 
unit had to be installed earlier in the synthesis of the alkynyl amine. 
 
 
The modification of the synthesis of the alkynyl amine provided the opportunity 
to a) optimize the route further and b) investigate the protecting group choice for the 
aziridine and amine nitrogens, in the event that DPM-deprotection became problematic at 
later stages. 
 Our previous protocol for the preparation of the alkynyl amine had used ethyl 
diazoacetate in the aza-Darzens reaction (Scheme 45). The resulting cis-aziridinyl ester 
was converted to the corresponding amine via saponification, amide coupling and 
reduction. Two possible modifications of this sequence of reactions are outlined in 
Scheme 45, namely, substituting the diazoacetate with a diazoacetamide in the aza-
Darzens reaction to directly provide the cis-aziridinyl amide, thereby shortening the 
synthesis by two steps. The second option utilizes the aza-Darzens reaction with the 
diazoacetate to provide the aziridinyl ester, which can then be reduced with DIBAL to the 
Scheme 44. Alkyne Substitution 
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aldehyde and transformed to the amine using reductive amination. This would shorten the 
synthesis by one step. 
 
 
The preparation of the imine (124) required for the aza-Darzens reaction, starts 
with commercially available 2-butyne-1,4-diol (Scheme 46). Monobenzylation of the diol 
is followed by oxidation to the aldehyde (127).
96
 The aldehyde is then treated with 
diphenylmethyl amine to yield imine 124 (E:Z ratio = 1:0.6). At this stage, an alternate 
aziridine protecting group, i.e. the bis(p-methoxyphenyl)methyl (bis-PMP), was 
introduced in case DPM-deprotection was problematic at later stages.  
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Scheme 45. Proposed Optimization of Alkynylamine Synthesis 
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The imines were then subjected to the previously optimized conditions for the 
triflic acid catalyzed aza-Darzens reaction with ethyl diazoacetate (Scheme 46). The 
DPM-imine (124) initially yielded no reaction with 25 mol% triflic acid and equimolar 
ethyl diazoacetate. Increasing the equivalents of triflic acid and ethyl diazoacetate, 
however, improved the yield of the desired cis-aziridine 128. The bis(PMP)-imine (129) 
yielded 8% cis-aziridine 130 under standard catalytic triflic acid conditions. In this case, 
an acid screen with both Brønsted and Lewis acids (CSA, SnCl4, TiCl4) produced no 
aziridine. Methanesulfonic acid treatment of bis(PMP)-imine 129 resulted in deprotection 
and hydrolysis to the aldehyde. Since imine deprotection was competing with the aza-
Darzens reaction, and the desired addition was likely to be slower with the electron-rich 
bis(PMP) group, 10 equivalents ethyl diazoacetate and 120 mol% triflic acid were used. 
Scheme 46. Preparation of the cis-Aziridinyl esters 127 and 129 
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The yield increased to 24% cis-130 but the reproducibility of this reaction varies because 
of competitive imine decomposition. 
At this stage, the aza-Darzens reaction of imine 124 with diazoacetamide 125 was 
investigated. As mentioned previously, this would directly lead to amide 126, eliminating 
the need to saponify ester 128 and then couple with diphenylmethyl amine. 
The use of diazoacetamides instead of diazoacetates has been documented for 
both the Darzens and the aza-Darzens reactions.
97,98,99,100,101,102,103,104
 The Darzens 
reaction with diazo-N,N-dimethylacetamide generated predominantly cis-epoxides for 
both aryl and aliphatic aldehydes.
97,98
 The diastereoselection for the aza-Darzens reaction, 
however, had mixed results. In general, the literature indicates that aryl imines with 
electron-withdrawing groups on the nitrogen (Boc, SES) favored the trans-aziridine 
(Scheme 47).
99,100,101
 The substitution on the diazoacetamide did not appear to affect the 
diastereoselection (mono- and di- substitution with aryl and alkyl groups). Maruoka 
postulated that the trans selectivity arises from the preference of the rotamer (131) with 
the antiperiplanar orientation of the aryl substituent of the imine and the amide group of 
the diazoacetamide. The formation of the cis-aziridine would require a synclinal 
orientation of these two groups, which would be destabilized by the steric repulsion 
(Scheme 47).
100
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In 2010, Wulff and coworkers reported the generation of cis-aziridines from N-
alkyl-protected benzaldimines with N-dialkyl diazoacetamides (Table 2).
102
 They 
reported that N-DPM imines are productive, albeit in lower yield than the N-MEDAM-
imines (Table 2, entry 3). Since our synthesis used DPM-imines, the aza-Darzens 
reaction should favor the cis-aziridine. The diazoacetamide of choice would be N-
monosubstituted, preferably with a DPM or similar group. 
 
Scheme 47. trans-Selective Aza-Darzens Reaction with Diazoacetamides 
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The preparation of diazoacetamide 125 commenced with the synthesis of tosyl 
hydrazide from tosyl chloride, followed by condensation with glyoxylic acid to provide 
tosylhydrazone 133.  The carboxylic acid is then converted to the acid chloride and 
coupled with N-hydroxysuccinimide to give succinimidyl diazoacetate (134).
105,106,107
 
Treatment of 134 with diphenylmethyl amine affords the requisite diazoacetamide in 
44% yield over three steps.
108
 Attempts to directly couple tosylhydrazone 133 to N-
hydroxysuccinimide with dicyclohexylcarbodiimide were unsuccessful,
109
 as were 
attempts to couple 133 with diphenylmethyl amine. 
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Table 2. cis-Aziridination with Various Imines 
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Treatment of imine 124 with diazoacetamide 125 under standard Brønsted acid-
catalyzed aza-Darzens reaction conditions gave no reaction despite using a stoichiometric 
amount of triflic acid. This was presumably due to the insolubility of the diazoacetamide 
in propionitrile. The diazoacetamide was soluble in THF and dichloromethane, but these 
reactions also returned starting material at −78 °C. At higher temperatures, the 
conversion was slightly improved but 
1
H NMR analysis of the reaction mixture did not 
show cis-aziridine 135. Using dichloromethane at −20 °C gave a side product that was 
possibly the trans-aziridine 136 (entry 6). A screen of Lewis acids revealed BF3•OEt2 to 
be the most effective in achieving conversion of starting material, and when repeated on a 
slightly larger scale, provided enough material for purification and characterization. Upon 
isolation, the predominant product was found to be the trans-aziridine (136, 8% yield).  
 
Scheme 48. Synthesis of Diazoacetamide 125 
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Looking back at the literature, soon after Wulff’s initial report on cis-aziridination 
with N-alkyl-protected benzaldimines with N-dialkyl diazoacetamides, they reported the 
formation of trans-aziridines from N-alkyl-protected aryl and aliphatic imines with N-
mono-alkyl- or N-mono-aryl-substituted diazoacetamides. Further studies using ONIOM 
calculations led to the hypothesis that the key interaction responsible for the switch in 
diastereoselection of the aza-Darzens reaction with diazoacetamides originated from a 
hydrogen bonding interaction between the amidic hydrogen and an oxygen atom in the 
chiral counterion (in this case, VANOL-polyborate).
103,104
 The possibility of hydrogen 
bonding explains why our aza-Darzens reaction with a monosubstituted diazoacetamide 
favored the trans-aziridine. 
Since diazoacetates favor cis-aziridines, the aza-Darzens reaction was attempted 
using succinimidyl diazoacetate, which is the activated ester precursor to diazoacetamide 
125. If this reaction produced the cis-aziridine, amide 126 could be easily obtained by 
Table 3. Optimization of aza-Darzens Reaction with Diazoacetamide 125 
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coupling the activated ester with diphenylmethyl amine. The reaction was performed in 
acetonitrile from −78 °C to 20 °C but yielded a complex mixture with no promising 
aziridine peaks. 
Since MMC requires the cis-aziridine, and using the diazoacetamide in the aza-
Darzens formed the trans-aziridine, this modification was no longer feasible. However, 
the aza-Darzens reaction with ethyl diazoacetate had successfully produced cis-aziridines 
128 and 130. Using the previously established route (Scheme 45), the ethyl ester of the 
aziridine (128) was subjected to saponification conditions (NaOH, EtOH/H2O), which 
unfortunately resulted in aziridine ring opening. Trimethyltin hydroxide
110
 and lithium 
hydroperoxide
111
 gave the same result. Milder conditions such as potassium silanolate 
gave no reaction.
112
 Direct ester to amide conversion using potassium tert-butoxide and 
diphenylmethyl amine was also unsuccessful.
113
 This indicated the necessity to follow the 
second of the suggested modifications in Scheme 45.  
To that end, aziridinyl ester 128 was treated with DIBAL and the resulting 
aldehyde was converted to amine 122 using reductive amination with diphenylmethyl 
amine followed by sodium cyanoborohydride with catalytic acetic acid (Scheme 49).
68114
 
Amines 138 and 140 were prepared in a similar fashion. 
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At this stage, the amine substrates for the aminomercuration-quinone coupling 
have been successfully synthesized with the desired C10-functionalization. The general 
route to the amine substrates has been shortened by using a DIBAL reduction and 
reductive amination to convert the aza-Darzens ester product to the requisite amines. 
Additionally, in an effort to further shorten the synthesis, a diazoacetamide was used in 
the aza-Darzens reaction instead of a diazoacetate; it is interesting to note that this fairly 
simple switch resulted in the formation of the undesired trans-aziridine as the major 
product. 
2.8.2. Enamine-Quinone Coupling: Tandem Formation of N4-C9a, C9-C8a Bonds 
 The coupling of amine 122 and quinone 66 was examined (Table 4). Standard 
conditions using mercuric chloride and triethylamine in THF resulted in decomposition 
of the amine while the quinone remained unreacted. The key difference between amines 
68 and 115 – which had successfully undergone aminomercuration and coupling – and 
Scheme 49. Preparation of Differentially Protected Amines 122, 138 and 140 
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amine 122 lies in the greater steric bulk of the benzyloxymethylene substituent on the 
alkyne. It stands to reason that this inhibited either the initial aminomercuration step or 
the subsequent quinone addition.  
 
 
If the problem lay in the first step i.e. aminomercuration, the reaction should 
ideally yield unreacted amine, though it is possible that the amine decomposed upon 
exposure to mercuric chloride, prior to cyclization. In order to facilitate 
aminomercuration, the more reactive mercuric triflate was used.
115
 However, in this case, 
the amine was unreactive at room temperature up to 45 °C. When the reaction was heated 
to 70 °C, TLC showed some consumption of the amine at which point the quinone was 
added. On continuing the reaction at 45 °C, the amine was completely consumed but the 
quinone remained untouched. Purification of the reaction mixture led to isolation of some 
                                                 
115
 Hg(OTf)2 preparation: Nishizawa, M.; Morikuni, E.; Asoh, K.; Kan, Y.; Uenoyama, K.; Imagawa, H. 
Synlett 1995, 1995, 169,170. 
Table 4. Enamine Formation and Coupling Attempts 
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benzyl alcohol; this indicates that while the amine is reacting, perhaps even cyclizing, 
Hg(OTf)2 is promoting the elimination of the benzyloxy group. Similar results were 
observed with mercury(II) iodide catalyzed aminomercuration and palladium(II)-
catalyzed aminopalladation; no reaction was observed with zinc acetate.
116,117
  Control 
reactions for Hg(OTf)2 and Pd(acac)2 were run with the terminal alkyne (68) and 
produced expected N,O-ketal 88 without noticeable decomposition of the starting amine. 
Amine 122 was also treated with 10 mol% triflic acid to see if any cyclization occurred, 
however, only the triflic acid salt of the amine and unreacted amine were observed. 
Due to the complex mixtures obtained during the reaction, the decomposition 
product of the amine could not be determined. This left the actual pathway of 
decomposition unknown: as mentioned previously, decomposition could occur prior to 
hydroamination-cyclization. It is also possible that the cyclization was occurring, but the 
subsequent quinone addition was slow or nonexistent – perhaps due to the sterics at the 
nucleophilic enamine position – which could result in decomposition of the highly 
reactive pyrrolidine enamine. In order to test this hypothesis, the reaction was quenched 
with acetyl chloride, which has a more accessible electrophilic site than the quinone. 
Acetyl chloride has been previously incorporated into the pyrrolidine enamine formed 
from the terminal alkyne 68;
65
 however, with amine 122, complex mixtures were 
obtained. N-Bromosuccinimide was also used to quench the intermediate, but led to the 
same results as with acetyl chloride. This implied that the quinone was not the sole 
problem. It was also possible that while most of the quinone did not react, some coupled 
product could form but might be prone to decomposition. Previous work had shown that 
                                                 
116
 Prior, A. M.; Robinson, R. S. Tetrahedron Lett. 2008, 49, 411-414. 
117
 Lei, A.; Lu, X. Org. Lett. 2000, 2, 2699-2702. 
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coupled quinone product 123 had been unstable and decomposed within a few hours; the 
coupled hydroquinone products however were more stable.
69
 In the formation of 
spiroketal 116, the hydride source for the reduction of the quinone to the hydroquinone 
was unknown. To this end, the reaction was performed with mercuric chloride and 
quinone 66 followed by addition of sodium borohydride to aid in the reduction to the 
hydroquinone, but the results were no different from the standard coupling reaction. 
All these experiments led to the following conclusions: a) while the sterics at the 
alkyne position could inhibit either the cyclization or the subsequent quinone addition, 
the results did not conclusively determine the problematic step of this addition; however, 
since the amine did react, it seems likely that the intermediate enamine is forming, but 
decomposes before addition to the quinone; and b) using other more reactive and less 
hindered electrophiles did not encourage enamine addition, implying that the steric bulk 
at the nucleophilic position of the enamine could be inhibiting the addition. The logical 
solutions are to a) attempt to create a more stable enamine intermediate so that heat 
and/or acid conditions could be used to force the Michael addition, and b) to use a 
different substituent on the alkyne. Since MMC requires an alcohol oxidation state at the 
alkyne carbon, and the enamine requires an electron-neutral or electron-donating group 
for a successful addition, and as we have now learned, it requires a small group as well, 
this limits the choices, including a methyl-protected alcohol where the deprotection 
conditions would be incompatible with sensitive functionalities like the aziridine. As a 
result, the next step is to attempt to create a more stable enamine intermediate. 
66 
 
2.8.3. Cyclization of the Alkynyl Amine: A Brief Look at Haloamination Literature 
 The ideal enamine intermediate envisioned was a haloenamine. With a 
haloenamine, it would be possible to perform the Michael addition and then dehalogenate 
to reform the enamine, or perform a metal-catalyzed coupling. Haloenamine formation 
had been briefly investigated previously, though unsuccessfully, when the 
aminomercuration reaction was quenched with NBS (Table 4). Here, it is investigated in 
more detail. 
 Previous literature reports have utilized halonium reagents in inter- and intra-
molecular haloamination reactions, though mostly with alkenes. N-Halosuccinimides are 
commonly used, either alone or in conjunction with metal catalysts (Scheme 50). Nishida 
reported the intramolecular haloamination reaction of N-halosuccinimide reagents with o-
aminostyrene derivatives to form the corresponding 2,3-dihydroindoles.
118
 For the more 
recalcitrant NCS, they used catalytic ytterbium triflate and trimethylsilyl chloride to 
promote the reaction, though still in low yield. Additionally, Sudalai reported 
bromoamination using N-bromosuccinimide and tosyl amine with styrene derivatives.
119
 
Notably, they were able to obtain both regioisomers selectively in high yields by 
changing their catalyst. More recently, Yeung reported a guanidine synthesis using a one-
pot amine addition to dimethylcyanimide followed by bromoamination of the olefin.
120
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67 
 
 
Yudin also utilized N-bromosuccinimide in a haloamination reaction of styrene 
derivatives with an aziridine (Scheme 51).
121
 He proposed that the reaction proceeded via 
a nitrogen-centered aziridinyl radical. As outlined below, halogenation of the aziridine is 
followed by homolysis of the N-X bond. Addition to the alkene, followed by 
recombination of both the vinyl and halogen radicals provides the haloamination product. 
 
                                                 
121
Yang, X.; Yudin, A. K. Synlett 2007, 2912-2918. 
Scheme 50. N-Halosuccinimide Promoted Haloaminations 
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 An alternative to N-halosuccinimides is N,N-dichloro-p-toluenesulfonamide 
(TsNCl2) (Scheme 52). Li used TsNCl2 as the nitrogen and halogen source in the 
haloamination of enones in the presence of catalytic CuOTf.
122
 In this case, the 
regioselectivity of addition was found to be dependent on the ketone substituent. More 
recently, Feng reported an asymmetric chloroamination using TsNCl2 in a scandium 
triflate catalyzed reaction with tosyl amine and enones; bromoamination and 
iodoamination under similar conditions were performed using NBS and NIS 
respectively.
123,124,125
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Scheme 51. Yudin’s Haloamination Using a Nitrogen-Centered Aziridinyl Radical 
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 A few other selected examples of haloaminations are shown in Scheme 53. Lu 
reported a two-step protocol involving protection of an alcohol as its carbamate, which 
then underwent an intramolecular haloamination in the presence of palladium acetate, 
copper(II) halide and lithium halide.
126
 In 2009, Lu used a similar procedure with alkynyl 
anilines in the presence of copper(II) bromide to form indoles.
 127
 Nishikawa reported that 
propargyl and homopropargyl guanidines, when treated with pyridinium tribromide in the 
presence of potassium carbonate, yielded five- and six-membered cyclic guanidines.
128
 
This methodology was then utilized towards his synthesis of the saxitoxin skeleton.
129
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Scheme 52. TsNCl2 Promoted Haloaminations 
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2.8.4. Cyclization of the Alkynyl Amine: Formation of the N4-C9a Bond 
Treatment of amine 122 with N-iodosuccinimide in dichloromethane yielded a 
less polar spot by TLC (Scheme 54). No further conversion was obtained and the reaction 
was purified by column chromatography on silica gel. 
1
H NMR analysis of the crude 
reaction mixture exhibited a mixture of two compounds and succinimide. However, no 
major product was observed following column chromatography. It is possible that the 
less polar spot observed was the N-iodoamine, which would be unstable to silica gel 
chromatography. In a separate experiment, the amine was treated with NBS. TLC 
monitoring showed immediate conversion to a less polar spot followed by rapid 
conversion to a more polar spot (within a few minutes at 0 °C). 
1
H NMR analysis of the 
crude and purified reaction, however, showed no desired product or starting material. 
Scheme 53. Miscellaneous Haloamination Procedures 
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When amine 122 was treated with NCS and potassium carbonate to assist in 
deprotonation of the amine, there was no reaction. 
 
 
 Treatment of amines 122 and 138 with pyridinium tribromide and potassium 
carbonate in dichloromethane-water overnight led to the formation of imine 141. With 
amine 122, deprotection of the diphenylmethyl group of the amine nitrogen was observed 
by the disappearance of the methine and aromatic protons by 
1
H NMR. The deprotection 
of the amine, and not the aziridine, was confirmed by subjecting amine 140 to the 
reaction conditions. Deprotection of the diphenylmethyl group was observed but the 
bis(PMP) group was still in place. Amine 138 also showed deprotection of the amine 
bis(PMP) group but not the aziridine DPM group. The structure of imine 141 was 
assigned using 
1
H NMR, 
13
C NMR, DEPT and COSY experiments. 
13
C NMR and DEPT 
of 141 revealed the presence of a quaternary carbon at 60 ppm (C-Br2) and 172 ppm 
(C=N), consistent with the absence of the expected enamine. 
1
H NMR and COSY 
showed no change in the coupling of the starting material, except for a W-coupling 
between one pyrrolidine proton and the aziridine proton. HRMS and IR provided 
confirmation of the assigned structure. 
 
Scheme 54. Attempted Haloamination with N-Halosuccinimides 
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 The mechanism of formation of imine 141 can occur via a radical pathway, 
similar to Yudin’s proposed haloamination mechanism (Scheme 51), or via an ionic 
pathway (Scheme 56). Pyridinium tribromide exists in equilibrium with pyridinium 
hydrobromide and bromine. Addition of a bromonium ion to the alkyne followed by 
nucleophilic attack of the amine gives pyrrolidine enamine 143. Enamine addition to a 
second equivalent of bromonium ion gives iminium 144. Subsequent deprotection of the 
pyrrolidine nitrogen would lead to imine 141.  
 
 
Scheme 55. Haloamination with Pyridinium Tribromide 
 
 
 
 
Scheme 56. Proposed Mechanism of Formation of Dibromoimine 141 
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 Additionally, the reaction also produced ketone 145 (Scheme 57). This was 
evident from the 
13
C NMR which showed a peak at 191.8 ppm. The remaining 
spectroscopic data was also consistent with the ketone structure. The ketone could result 
from hydrolytic opening of a common intermediate (140) in the pathway to the imine 
(141). Following opening to the ketone, oxidation of the diphenylmethyl group can occur 
by halogenation of the amine followed by elimination of HBr. The imine functionality of 
ketone 145 slowly hydrolyzed on standing in deuterated chloroform for 35 days to form 
benzophenone and the dibromoimine 141 (24% recovery). 
 
 
Repeated experiments suggested that 2 equivalents of pyridinium tribromide 
produced the ketone in low yield while 4 equivalents produced the imine as the major 
product. With bis(PMP)-amine 140, the corresponding dibromoimine 142 was produced 
in 27% yield and the corresponding deprotected ketone in 33% yield (Scheme 58). 
Scheme 57. Proposed Mechanism of Formation of the Ketone co-Product from Haloamination 
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Repeated experiments revealed an inconsistency in product yields; as a result, amine 122 
was used in later experiments. 
 
  
In order to investigate the reactivity of the imine, hydrolysis of imine 141 to the 
corresponding ketone was attempted using 0.1M HCl in ether; this led to decomposition 
of starting material. Using silica gel in ethyl acetate-water returned only starting material. 
Additionally, stability of both the imine and the ketone to reaction conditions (PyHBr3, 
CH2Cl2-H2O) was assessed, imine 141 decomposed after a few hours, while ketone 145 
remained mostly intact. 
While both the imine and ketone could be investigated in additions to the quinone, 
the higher yielding imine was chosen for further experimentation.  
2.8.5. Dibromoimine-Quinone Coupling: Formation of the N4-C4a Bond 
 The cyclization of the alkynyl amine set the stage for the Michael addition into 
the quinone. It was now important to assess the imine substrate for its ability as a Michael 
donor as it differed significantly from our previous enamine intermediates. Scheme 59 
outlines the overall strategy for the formation of the key bonds between the quinone and 
the amines. Thus far, the first step has always been cyclization of the alkynyl amine to 
form the pyrrolidine enamine (N4-C9a bond). When using the unsubstituted alkyne 68 
Scheme 58. Treatment of Amine 140 with Pyridinium Tribromide 
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and the methyl-substituted alkyne 115, the following Michael addition to the quinone 
occurred in one pot to form ketals 88 and 116 respectively. These Michael additions 
occurred through the enamine, thereby forming the C9-C8a bond. Our final goal was to 
use the pyrrolidine amine nitrogen to add into the quinone at C4a. Quinone 66 was used 
because the regioselectivity of addition to the quinone had to occur first at C8a, then at 
C4a (Scheme 22).  
 
 
 When using the benzyloxymethylene alkyne, we noticed that the one pot 
cyclization-coupling did not occur, presumably due to greater steric bulk at enamine 
carbon C9 (Scheme 59). Therefore, the best possible way to force addition of carbon C9 
to the quinone at C8a was to perform an intramolecular addition, by first adding nitrogen 
Scheme 59. Initial Strategy Towards Amine and Quinone Coupling 
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N4 to quinone carbon C4a. Revisiting quinone regioselectivity (Scheme 60, previously 
described in section 2.3), quinones 78, 44 and 80 would all be viable candidates as the 
first addition would occur at C4a. In the case of quinones 44 and 80, Michael addition 
would be followed by elimination. With quinone 78, Michael addition would result in the 
formation of the hydroquinone, which required re-oxidation to the quinone before further 
manipulations. 
 
 
 Now that nitrogen N4 was chosen to perform the first Michael addition to the 
quinone, the following two options existed (Scheme 61): addition of amine 122 followed 
by cyclization, or addition of dibromoimine 141. The end product of both pathways 
should only require intramolecular addition of enamine C9 to the quinone at C8a to give 
the MMC core. 
 
Scheme 60. Quinone Regioselectivity of the First Michael Addition 
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 Our investigation began with dibromoimine 141. We rationalized that since the 
imine center was fairly congested, unsubstituted quinone 78 would reduce steric 
crowding at least for one component of the reaction. Quinone 78 and dibromoimine 141 
were unreactive in benzene, methanol and THF even at reflux. At reflux in methanol, 
decomposition of the dibromoimine was observed. The reluctance of any reaction except 
slow decomposition seemed to indicate that the nucleophilicity of the imine was 
significantly dampened when compared to our previous amine nucleophiles. The key 
factors influencing the nucleophilic attack are steric congestion (neopentyl and cyclic 
nitrogen nucleophile) and electronic effects (two adjacent bromines). The steric 
congestion could conceivably be eased by debromination prior to addition; the electronic 
factor can be rectified by increasing the electrophilicity of the quinone. 
 To increase the electrophilicity of the quinone, a Lewis acid screen was 
conducted. In most of these cases, imine decomposition was observed. Treatment with 
alkylating agents such as the Meerwein salt or trimethylsilyl triflate resulted in 
decomposition as well. Brønsted acids such as acetic acid resulted in no reaction. In some 
cases, partial reduction of the quinone to the phenol was observed. This could be 
Scheme 61. Possibilities with N4-C4a Addition 
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explained by a hydride transfer from the aziridine DPM group to the Lewis acid-activated 
quinone. However, this hypothesis was not experimentally confirmed because treatment 
of 1 equiv. quinone with 3 equiv. aziridine and 1 equiv. SnCl4 resulted in decomposition 
of the aziridine and completely unreacted quinone (if the hydride transfer theory held, 
then the results would have been 2 equiv. unreacted aziridine and 1 equiv. phenol). 
 
 
 Since the Michael addition seemed to be problematic, imine 141 was treated with 
electrophiles that were more reactive than the quinone. Michael acceptors such as 
dimethylethylidene malonate and trans-β-nitrostyrene were unreactive, even in refluxing 
solvent. In the latter case, addition of a mild base (PBAM•HOTf) to assist in imine 
debromination did not help. The potent Michael acceptor, methyl vinyl ketone, did not 
react with the imine in benzene at reflux; the addition of a Lewis acid (diethylaluminum 
Table 5. Quinone Activation towards Dibromoimine Addition 
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chloride) resulted in immediate decomposition. Moving on to highly reactive non-
conjugated electrophiles like bromoacetyl bromide resulted in complex mixtures. 
Treatment with trimethyl aluminum in the hopes of a methyl transfer gave no reaction. 
The only electrophile that showed any reactivity without complete decomposition was 
benzyl chloroformate (Scheme 62). Initially, the goal had been to acylate the imine, 
followed by debromination to reform the enamine (153). To this end, the reaction was 
performed using base (triethylamine, benzyl amine) or zinc in different solvents. 
However, in each of these cases, the dominant product observed was ketone 152. The 
reaction, when repeated without any additives, also proceeded in moderate yield to 
ketone 152. This ketone was unsuccessfully treated with tin dichloride to do a 
Reformatsky-like reaction.
130
 It was also treated with n-butyllithium and then quenched 
with water to see if lithium-halogen exchange was a feasible avenue; however, only 
decomposition was observed.
131
 
 
 
 The addition was also attempted using Rapoport’s conditions.72 He had achieved 
addition of pyrrolidine to quinone 78 using cupric acetate monohydrate in the presence of 
                                                 
130
 Demir, A. S.; Tanyeli, C.; Mahasneh, A. S.; Aksoy, H. Synthesis 1994, 155-157. 
131
 Aoki, Y.; Oshima, K.; Utimoto, K. Synlett 1995, 1071-1072. 
Scheme 62. Imine Acylation with Benzyl Chloroformate 
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oxygen. In our case with dibromoimine 141, there was no reaction at room temperature 
and the imine decomposed upon heating. 
 
 
Final attempts to add the imine to the quinone used phenol 154 to effect a 
bromine transfer with the imine, which could then add in to give the desired product 
(Scheme 64). However, there was no reaction when the imine and phenol were heated at 
90 °C. After reaching reflux, imine decomposition was observed. The dibromoimine was 
also treated with potassium methoxide in acetonitrile to force formation of the 
hemiaminal, thereby increasing the nucleophilicity of the nitrogen, but this resulted in 
decomposition as well. 
 
 
Scheme 63. Addition using Rapoport’s Copper Acetate-Mediated Conditions 
 
 
 
 
Scheme 64. Bromine Transfer Attempt Using Phenol 154 
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 Since the imine itself could not add into the quinone, a slightly different approach 
was considered using the aziridine nitrogen of the dibromoimine to add to quinone 
carbon C4a. This harks back to the mitomycin rearrangement to isomitomycin (Scheme 
2). In Fukuyama’s total synthesis of MMC, most of the chemistry was performed on the 
isomitomycin structure, and the mitomycin skeleton was unveiled at the very end of his 
synthesis using the isomitomycin-mitomycin rearrangement (Scheme 3). We 
experimented with aziridine deprotection to determine its feasibility. Due to the presence 
of the benzyl ether and the bromines, reductive methods were not considered viable. 
Previously, treatment with benzoyl chloroformate had resulted in acylation of the imine 
followed by hydrolysis to the ketone (Scheme 62); this eliminated the acylation followed 
by hydrolysis strategy to deprotect the aziridine. This left oxidative cleavage to deprotect 
the aziridine (Table 6). Ceric ammonium nitrate did not give any reaction. Trityl 
tetrafluoroborate did not give any reaction with one equivalent, however, the addition of 
the second equivalent resulted in decomposition.
132
 This behavior was also observed with 
DDQ. Additionally, deprotection with TMSI-PPh3 was performed on a similar DPM-
protected aziridine (68) and resulted in decomposition of the aziridine.
133,134 
The aziridine 
was also treated with trifluoroacetic acid, and triethylsilane and trifluoroacetic acid, and 
N-bromosuccinimide.
135,136
 All of these conditions resulted in decomposition.
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In summary, the goal was to install a functionalized C10 onto the alkyne before 
cyclization and addition into the quinone. Installation of a functionalized C10 was 
achieved when the benzyloxyalkynyl amine 122 was successfully synthesized. 
Cyclization to forge the N4-C9a bond using standard aminomercuration conditions did 
not work; however, after investigating other metal-catalyzed and halonium-promoted 
cyclization, dibromoimine 141 was successfully prepared using pyridinium tribromide. 
Dibromoimine 141 – the key highly functionalized piece required to add into the quinone 
to form the N4-C4a bond – proved to be much too hindered to undergo a Michael 
addition. At this point, the next logical step is the addition of the amine nitrogen to the 
quinone first followed by cyclization (Scheme 61). 
 
2.9. Coupling Prior to Cyclization: Formation of the N4-C4a Bond 
 This section outlines our attempts to couple nitrogen N4 of the aziridine partner to 
the quinone. The initial aziridine substrate was the benzyloxyalkynyl amine (122). The 
Table 6. Deprotection Attempts on the Aziridine 
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conclusion of these experiments (see section 2.9.1.) led us to prepare a modified aziridine 
with a free amine for the Michael addition.  
2.9.1. Addition of the Benzyloxyalkynyl Amine to the Quinone 
 We attempted to perform the Michael addition with amine 122 and quinone 78 
under our standard pyridinium tribromide cyclization conditions to see if any of the 
reactive intermediates in the dibromoimine formation would react with the quinone, but 
no coupling was detected (Table 7). Dibromoimine 141 was produced in 11% yield, and a 
trace amount of ketone 145 was observed while the quinone remained unchanged.  
 Amine 122 was treated with quinone 80 under basic conditions (triethylamine, 
potassium carbonate, DBU) at refluxing temperatures (THF, dichloromethane), but no 
reaction was observed (Table 7). Lewis acidic conditions (Sc(OTf)3) also resulted in no 
reaction. Amine 138, which should have a slightly more nucleophilic nitrogen because of 
the electron-donating bis(PMP) protecting group, was treated with sterically less hindered 
benzoquinone under basic conditions (pyridine, DBU) in benzene; this also resulted in no 
reaction. The Cbz-protected amine 152, obtained by treating the dibromoimine with 
benzyl chloroformate, was also treated with unsubstituted quinone 78 in the presence of 
Sc(OTf)3 at 0 °C, but this gave a complex reaction mixture. 
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 From these experiments, it is evident that the amine nitrogen is not sufficiently 
reactive when protected. We know from previous work that free amine 157 will add into 
the dibromoquinone (Scheme 65).
68
 This indicates that the quinone substituents should 
not hinder the Michael addition, and the obvious course of action is to use a free amine.   
 
 
The free amine 149, obtained as a side product with pyridinium tribromide, was 
treated with quinone 80 in refluxing toluene (Scheme 66). Treating amine 149 and 
quinone 80 with pyridine in refluxing THF gave no reaction; however, taking the reaction 
Table 7. Addition of Amine Nitrogen N4 to Quinone 
 
 
 
 
Scheme 65. Addition of a Free Amine into the Dibromoquinone
68
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with pyridine in toluene to higher temperatures resulted in decomposition of the amine. It 
is not clear why this amine decomposed before the addition. It could be explained by the 
other reactive functionalities present. Intramolecular cyclization of the amine onto the 
ketone should form the dibromoimine, which has limited stability. While amine 149 did 
not cyclize to the dibromoimine when stirred in diethyl ether with 4Å molecular sieves, 
basic conditions under high temperatures could have resulted in cyclization. If this is the 
case, an alkynyl functionality similar to 122, even if substituted, might not interfere with 
the addition to the quinone. 
 
 
 In order to obtain amine 161, deprotection of the diphenylmethyl group was 
attempted (Table 8). Treatment of amine 122 with DDQ in dichloromethane and water 
gave only starting material. Heating the amine with DDQ in benzene with 4 Å molecular 
sieves formed the imine in 28% yield. Further treatment of the imine with 0.1 N aqueous 
HCl resulted in decomposition;
137
 
1
H NMR analysis of the crude reaction mixture 
indicated aziridine ring opening. Hydrolysis under milder conditions (i.e. saturated 
aqueous NH4Cl) gave the same result. Deprotection using trimethylsilyl iodide (generated 
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 Sampson, P. B.; Honek, J. F. Org. Lett. 1999, 1, 1395-1397. 
Scheme 66. Addition of Free Amine 149 into the Quinone 
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in situ from sodium iodide and trimethylsilyl chloride) was attempted but also resulted in 
complete decomposition.
133,134
 It is worthwhile to note that free amine 157 had been 
prepared by DPM deprotection using DDQ and 0.1 N aqueous HCl; in that case, a 
deprotection attempt using trifluoroacetic acid and triethylsilane resulted in 
decomposition.
68
  
 
 
 We also tried to prepare the free amine directly from the aldehyde (137) without 
having to resort to deprotection strategies. Aldehyde 137 was treated with hydroxylamine 
hydrochloride and pyridine to make the oxime, followed by reduction using lithium 
aluminum hydride.
138
 The oxime was observed by 
1
H NMR analysis of the reaction 
mixture after the first step; however, no product (161) or side products were discernible 
from 
1
H NMR analysis of the reaction mixture after reduction. 
 
                                                 
138
 Thomas, P. J.; Axtell, A. T.; Klosin, J.; Peng, W.; Rand, C. L.; Clark, T. P.; Landis, C. R.; Abboud, K. 
A. Org. Lett. 2007, 9, 2665-2668. 
Table 8. Deprotection Conditions for Amine 122 
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 We considered alternate methods to prepare the free amine and thought that an 
azide would be a good precursor for a free amine. Azides are relatively easy to prepare, 
and an aziridinyl azide has been prepared before.
65,68
 Additionally, azide reduction 
requires relatively mild conditions that would be compatible with the aziridine moiety.  
2.9.2. Preparation of Free Amine 165 
 The preparation of the azide starts from commercially available 
chloroacetaldehyde (Scheme 68). Condensation with diphenylmethyl amine followed by 
the Brønsted acid catalyzed aza-Darzens reaction with ethyl diazoacetate furnished 
aziridine 163. The chloride was then displaced with sodium azide to give the desired 
azide 164.
65,68
 
 
 
Scheme 67. Attempt to Prepare Free Amine 161 from Aldehyde 137 
 
 
 
 
Scheme 68. Preparation of the Aziridinyl Azide  
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 With the azide in hand, a quick experiment was run with the azide and the 
unsubstituted quinone (78) to see if a [3+2] cycloaddition would occur. The azide and the 
quinone were treated with triflic acid in acetonitrile at −20 °C and then quenched with 
water to hydrolyze any triazoline that formed, but only starting materials were observed. 
In a separate experiment, the azide and the quinone were heated in trifluorotoluene in the 
microwave at 80 °C. Slow consumption of the quinone was observed. The temperature 
was increased to 100 °C and 
1
H NMR analysis of the reaction mixture showed that the 
azide remained unchanged but the quinone was reduced to the hydroquinone. This 
reduction was intriguing especially as there was no source of a reducing equivalent; had 
the aziridine diphenylmethine been the hydride source, decomposition of 164 should have 
been observed. 
Staudinger reduction of the azide initially led to the formation of lactam 166, 
formed from the cyclization of reduced 164 (Scheme 69).
139
 Repeating the experiment 
with varying reaction times gave amine 165. Upon standing, regardless of whether the 
amine is in solution or kept as a solid, lactam 166 starts to form. It is to be noted that the 
cyclization occurs faster in solution, and lactam 166 can be observed after 1 day in a 
0.6:1 ratio with the amine. 
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 Vaultier, M.; Knouzi, N.; Carrié, R. Tetrahedron Lett. 1983, 24, 763-764. 
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 With amine 165 in hand, the coupling to the quinone can be attempted. 
Additionally, the inadvertent formation of lactam 166 provided an opportunity to test it in 
the coupling reaction as well. 
2.9.3. Formation of the N4-C4a Bond 
 The two aziridine pieces used to test the coupling reaction were lactam 166 and 
amine 165. Lactam addition to the quinone could be followed by installation of a two 
carbon unit on the quinone at C8a. If the two carbon unit contained a nucleophilic C9, 
then it could be used in an intramolecular addition to the lactam carbonyl, which would 
result in the formation of the C9-C9a bond as well as the hemiaminal required for MMC 
in one step.
50
 In brief, the lactam 166 did not react under any of the reaction conditions 
(Table 9), including DBU, potassium carbonate and sodium hydride.
140
 The cesium 
fluoride reaction conditions (entry 4) are known to promote addition of lactams to 
unsaturated esters but did not work in this case.
141
 
 
                                                 
140
 NaH deprotonation of amide: Perrin, C. L.; Lollo, C. P.; Hahn, C. S. J. Org. Chem. 1985, 50, 1405-
1409. 
141
 Han Ahn, K.; Jong Lee, S. Tetrahedron Lett. 1994, 35, 1875-1878. 
Scheme 69. Staudinger Reduction of the Azide 
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  Meanwhile, we were also investigating the amine addition to the quinone 
(Scheme 70). Amine 165, when treated with unsubstituted quinone 78 in triethylamine 
and benzene, merely cyclized to lactam 166 without quinone incorporation. When 
quinone 80 was used instead, amine 165 coupled readily to give the desired 
aminoquinone 169 in good yield. 
 
 
Table 9. Lactam Addition to the Quinone 
 
 
 
 
Scheme 70. Amine Addition to the Quinones 
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2.9.4. Functionalization of the Aminoquinone – Installing C9-10 Before Coupling 
Now that the amine is successfully coupled to the quinone, the final carbons 
required for MMC (C9, C10) need to be installed. Before we proceeded, we addressed 
two key considerations: a) the site of initial addition of the C9-10 unit (should the 
addition occur on the quinone first (C9-C8a) or the aziridinyl ester first (C9a-C9)), and b) 
the timing of the C9-10 addition (should the addition be done prior to coupling or to the 
coupled product 169). At the end of all these operations (formation of the C9-C8a, C9a-
C9, N4-C4a bonds), we should be left with an eight-membered ring intermediate similar 
to that in Kishi’s synthesis (Scheme 1), after which transannular cyclization of the amine 
(N4) to the ketone (C9a) will be the last step to construct the mitomycin core.  
 
 
Scheme 71 outlines a map of the bonds that need to be formed between the three 
pieces. We have already established formation of N4-C4a, and in the section that follows, 
attempts to add the C9-10 unit to the aziridinyl ester (165) and to the quinone (80) prior 
to the coupling are discussed. Additionally, studies related to the addition of the C9-10 
unit to the quinone moiety of the coupled aminoquinone 169 will be described.  
 
Scheme 71. Mapping the Bonds to be Formed  
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I. Addition of the C9-10 unit to the Aziridinyl Ester Prior to the Coupling 
Several functionalities were considered for the C9-10 unit. The key concern was 
the ability of the group to be transformed into the requisite carbamate of MMC using 
conditions compatible with the late stage intermediates. As shown in Scheme 72, the 
group chosen was an allyl silane, allowing us to close the eight-membered ring 
(transformation of 174 to 175) with a CAN allylation between the allyl silane and the 
vinylogous amide (reacting partners shown in blue).
142
 The allyl silane will be introduced 
using a Grignard addition of vinyl iodide 171 to Weinreb amide 170.  
 
                                                 
142
 Chandra, A.; Pigza, J. A.; Han, J.-S.; Mutnick, D.; Johnston, J. N. J. Am. Chem. Soc. 2009, 131, 3470-
3471. 
Scheme 72. Route to MMC with C9-10 Installation Prior to the Coupling 
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 The preparation of the Weinreb amide was fairly straightforward (Table 10). The 
use of isopropyl magnesium chloride as the base resulted in the formation of only lactam 
166.
143
 We hypothesize that the Grignard acted as a one electron reductant, ultimately 
converting the azide to the amine, which then cyclized under the strongly basic reaction 
conditions to the lactam. The more traditional method using trimethylaluminum gave no 
reaction, but using butyllithium resulted in clean and complete conversion of the ester to 
the desired Weinreb amide.
144,145
  
 
 
 Scheme 73 details the proposed syntheses of the allyl silanes (171 and 181). In 
order to make vinyl iodide 171, the Grignard of propargyl bromide can attack 
trimethylsilyl chloride to yield the propargyl silane (178), which could then be reduced 
with DIBAL and quenched with iodine to provide vinyl iodide 171.
146,147
 The vinyl 
bromide (181) can be prepared starting from dibromopropene 179. Substitution of the 
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 Williams, J. M.; Jobson, R. B.; Yasuda, N.; Marchesini, G.; Dolling, U.-H.; Grabowski, E. J. J. 
Tetrahedron Lett. 1995, 36, 5461-5464. 
144
 Sha, C.-K.; Huang, S.-J.; Zhan, Z.-P. J. Org. Chem. 2002, 67, 831-836. 
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 Roche, C.; Labeeuw, O.; Haddad, M.; Ayad, T.; Genet, J.-P.; Ratovelomanana-Vidal, V.; Phansavath, P. 
Eur. J. Org. Chem. 2009, 3977-3986. 
146
 Beignet, J.; Jervis, P. J.; Cox, L. R. J. Org. Chem. 2008, 73, 5462-5475. 
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 Tietze, L. F.; Völkel, L.; Wulff, C.; Weigand, B.; Bittner, C.; McGrath, P.; Johnson, K.; Schäfer, M. 
Chem.—Eur. J. 2001, 7, 1304-1308. 
Table 10. Preparation of the Weinreb Amide 
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bromide with a trichlorosilyl group, followed by conversion to a trimethylsilyl group 
would yield the desired vinyl bromide.
148,149,150
 Both approaches failed in the first step 
despite varying the reaction conditions. In the case of the vinyl iodide, the propargyl 
silane was not formed despite varying the reaction conditions (Mg, MeMgBr, 
n
BuLi). No 
propargyl bromide (or the allene with which it is in equilibrium) or product was seen by 
1
H NMR in any of the crude reaction mixtures. 
1
H NMR analysis of the reactions before 
and after the addition of TMSCl revealed a significant change in the peak shifts (possible 
decomposition on adding TMSCl), and comparison of the spectra between reactions 
showed no similarities. In the MeMgBr reaction, distillation from the reaction mixture 
did not give any distillate at the expected temperatures for the starting material or 
product. In the case of the vinyl bromide, the trichlorosilane was not successfully 
prepared.  
 
 
 At this point, the addition into the quinone before coupling was also considered. 
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 Nishiyama, H.; Narimatsu, S.; Itoh, K. Tetrahedron Lett. 1981, 22, 5289-5292.  
149
 Furuya, N.; Sukawa, T. J. Organomet. Chem. 1975, 96, C1-C3. 
150
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Scheme 73. Synthetic Approach Towards the Allylsilanes 
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II. Addition of the C9-10 unit to the Quinone Prior to the Coupling 
Prior to the investigation of the azide and aminoquinone, some work had been      
done on a slightly different route. The goal of this route was similar to the current goal in 
the addition of the C9-10 unit to the quinone before coupling. However, the difference 
was to create the C9-C9a bond before addition of the amine component to the quinone 
(N4 to C4a). Therefore the Michael addition of C9-10 into the quinone was followed by 
reduction and further testing of the C9-C9a coupling. The initial experiments in this route 
are relevant to the current work, and so will be discussed briefly first.  
To begin, we experimented with addition to the quinone which would be followed 
by reduction to the hydroquinone. Nitromethane was chosen as a good nucleophile for the 
Michael addition (Scheme 74) as the resulting nitro group would make it easy to 
deprotonate the C9 carbon for addition into the ester group of 164. Unfortunately, due to 
the ambident nucleophilicity of the nitro group, the addition occurred via the oxygen. The 
1
H NMR spectra of the reaction after work up showed that one methoxide group had 
disappeared but the methylene expected from nitromethane addition through the nitrogen 
was not present. It was deduced that the methoxide was displaced by attack of the oxygen 
of the nitro group followed by hydrolysis during the work up to produce the hydroxyl.  
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The next C9-10 unit chosen was methyl acetate since it could undergo Claisen 
condensation with the aziridinyl ester (164) and be transformed to the alcohol with 
relative ease. Deprotonation of methyl acetate using potassium methoxide in acetonitrile 
followed by addition to the quinone unfortunately gave a complex reaction mixture. 
Diethyl malonate, a much better Michael donor, was then used (Table 11). Preliminary 
reactions were not promising when a strong base (sodium ethoxide) gave complete 
consumption of starting material but no desired product, and milder bases (pyridine, 
diisopropylethyl amine) gave no reaction.  
 
Scheme 74. Nitromethane Addition to the Quinone 
 
 
 
 
Table 11. Attempted Preparation of Quinone 185 
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Interestingly enough, when the base and quinone were combined, the color of the 
solution turned from the bright orange of the quinone to green; however, on removing the 
solvent or quenching the base, the reaction mixture turned orange again and showed 
unreacted starting material. If the color change back to orange indicated a retro-Michael, 
then the Michael adduct could be trapped with an in situ reduction to the hydroquinone. 
Therefore, the quinone was treated with diethyl malonate and diisopropylamine, followed 
by sodium borohydride. Though this produced the hydroquinone, no malonate was 
incorporated. When the base was switched to sodium hydride, hydroquinone 186 and 
lactone 187 were produced (Scheme 75). Hydroquinone 186 was treated with potassium 
carbonate in dichloromethane at reflux but did not convert to lactone 187. The 
hydroquinone was also treated with triethylamine in THF but decomposed at reflux. In 
situ protection of the hydroquinone by addition of TBSCl after sodium borohydride did 
not give any protected hydroquinone, but produced lactone 187 in 44% yield while some 
silylated lactone was also isolated. As a result, lactone 187 was used in further 
experiments because it was consistently produced in the reaction and in better yield.  
 
 
 The efforts to perform the Claisen condensation of lactone 187 with the aziridinyl 
ester (164) can be summarized as follows: a) basic conditions with sodium ethoxide in 
Scheme 75. Preparation of Hydroquinone 186 and Lactone 187 
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ethanol (or ethanol:THF) at reflux gave no reaction, and b) sodium hydride in DMF at 
130 °C for 5 min in the microwave gave unreacted ester 164 and decomposition of the 
lactone. It is interesting to note that the aziridine was not affected by basic conditions, as 
was previously observed with butyllithium (Scheme 33). Attempted decarboxylation of 
the lactone under Krapcho conditions resulted in decomposition as well. A one-pot 
attempt with the quinone (66), ethyl acetate, aziridinyl ester (164) and sodium ethoxide 
followed by sodium borohydride also gave no reaction. 
Perhaps in view of the work just described, the desire to create the N4-C4a bond 
before the C9a-C9 bond is validated, as we have already successfully coupled amine 165 
to quinone 80. Towards our current goals, the malonate was added to quinone 66 using 
the same method as before with sodium hydride (Scheme 76). Addition of amine 164 to 
the quinone under standard conditions using triethylamine in benzene resulted in 
complete decomposition. The stability of the quinone was limited to a few days at room 
temperature in solution, but this seemed to be shortened significantly under mildly basic 
conditions. 
 
 
Since neither the amine nor the quinone was recovered from the reaction mixture, 
quinone 185 was also treated with benzylamine in benzene to see if the problem was the 
Scheme 76. Preparation of Quinone 185 and Subsequent Coupling 
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stability of 188; however, this also resulted in decomposition. It is acknowledged that the 
malonate methine is highly acidic and could play a role in the reaction decomposition 
pathway. This could be addressed by reversing the order of couplings, adding the 
malonate after coupling the quinone and the amine. 
2.9.5. Functionalization of the Aminoquinone – Installing C9-10 After Coupling 
I. Addition of the C9-10 Unit to the Quinone Moiety of the Coupled Product 
 The addition of the C9-10 unit to the aminoquinone (169) was also investigated at 
the same time as the malonate addition to the quinone (66) from the preceding section. 
The results that are discussed below occurred before the successful addition of the 
malonate into the quinone. After outlining those results, the malonate addition to the 
aminoquinone will be discussed immediately after. 
 Scheme 77 shows an overview of the additions to aminoquinone 169. These 
studies began with a CAN allylation using allyl trimethylsilane (I).
142
 Using 2 equivalents 
of CAN in acetonitrile and warming from 0 °C to room temperature resulted in no 
reaction; the addition of 2 more equivalents of CAN gave complete conversion of the 
aminoquinone but the 
1
H NMR spectrum of the reaction mixture was complex with some 
formation of aldehyde 189. This indicated that aminoquinone 169 was reacting with CAN 
but not the allyl silane. The reaction was attempted again with an increased amount of 
allyl silane, but resulted in a complex mixture in which aldehyde 189 was not observed. 
Fluoride assisted addition of allyl trimethylsilane (II) using tetrabutylammonium fluoride 
in dichloromethane showed starting material by TLC while the 
1
H NMR analysis of the 
crude reaction mixture showed consumption of starting material. The resulting side 
products decomposed during purification by silica gel column chromatography. The 
100 
 
addition of allyl magnesium bromide (III) to the quinone in THF at −78 °C showed some 
starting material and undetermined side products by 
1
H NMR analysis of the crude 
reaction mixture. When the reaction was repeated and warmed from −78 °C to room 
temperature, complete decomposition was observed. Cuprate addition (IV) with allyl 
magnesium bromide and cuprous iodide in THF returned mostly starting material with a 
small amount of conversion to the same side product observed with the first Grignard 
reaction. The crude reaction mixtures were combined and purified by column 
chromatography but none of the fractions yielded any compounds with diagnostic allyl 
peaks. Control reactions for the cuprate addition were performed with dimethylethylidene 
malonate and quinone 66. The former gave the expected product but the quinone returned 
starting material and some side products with no allyl peaks incorporated. 
 
 
Scheme 77. Overview of Aminoquinone Additions 
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 The ability of the enamine system to add to electrophiles was unclear because it 
has more of the characteristics of a vinylogous amide than an enamine. That said, the 
amine nitrogen should provide reactivity similar to an N-alkyl enamine. The additions to 
electrophiles began with allyl iodide (5 equivalents) in acetonitrile at reflux but no 
reaction was observed (V). Ethyl bromoacetate also gave no reaction at 85 °C for 5 min 
in the microwave in acetonitrile (VI).
151
 This reaction was then heated at 100 °C for 
30 min (monitored in 10 min intervals) and showed slow consumption of the starting 
material. Analysis of the reaction mixture by 
1
H NMR revealed a complex mixture with 
no aziridine peaks, indicating that the aziridine nitrogen acylated faster than enamine 
addition. Treatment of the aminoquinone with allyl bromide and potassium carbonate in 
DMF (VII) suggested that N-allylation had occurred. The allylated product co-eluted 
with aldehyde 189 (seen previously in I) during column chromatography, and was 
consistently a 3:1 mixture of 190:189 by 
1
H NMR analysis. Homonuclear decoupling 
experiments on the mixture assisted assignment of product peaks despite some peak 
overlap, and high resolution mass spectrometry confirmed the presence of the bromide. 
The undesired aldehyde 189 has been observed twice so far: under oxidative 
conditions with CAN and allyl silane in acetonitrile (Scheme 77, I) and under non-
oxidative basic conditions with allyl bromide and potassium carbonate in DMF (Scheme 
77, VII). While the mechanism of its formation is uncertain, a possibility is outlined in 
Scheme 78. CAN allylation of aminoquinone 169 would proceed through the vinylogous 
amide system and result in the formation of intermediate 191. This intermediate can also 
arise under allylation conditions with allyl bromide and potassium carbonate through 
addition via the enamine system of 169 (the major product N-allyl 190 arises from direct 
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 Huang, Z.-T.; Liu, Z.-R. Chem. Ber. 1989, 122, 95-100. 
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amine attack on allyl bromide). A [1,3]-hydride shift followed by elimination of a 
molecule of HBr will form imine 193. This would then hydrolyze under aqueous work up 
procedures to form aldehyde 189.  
 
 
 In the allyl bromide case, imine 191 can also be produced through a Claisen 
rearrangement of N-allylated aminoquinone 190. The Claisen rearrangement was an 
interesting idea from our point of view because it would install the allyl group onto the 
quinone. The rearrangement intermediate 191 does not seem electronically favorable 
because it breaks the extended conjugation of the quinone. This might help explain why 
191, if it is formed during the reaction, tautomerizes to 192. Thus far, the reactions had 
aqueous work up procedures (to remove CAN and DMF) but if 193 could be obtained, a 
reduction of the imine will give the desired adduct (in hydroquinone form).  
To this end, the Claisen rearrangement was attempted by heating N-allylated 
aminoquinone 190 in toluene from 80 °C to 110 °C (Scheme 79). No reaction was 
observed, so the reaction was repeated in trifluorotoluene in the microwave. At 135 °C, 
Scheme 78. Rationale for Aldehyde 189 Formation 
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there was no reaction after 10 min but slow consumption of starting material was 
observed after another 20 min of heating. Unfortunately, when the reaction was heated 
for another 40 min, the starting material decomposed. Similar results were obtained when 
190 was treated with triethylamine (to promote imine tautomerization/debromination) in 
trifluorotoluene: no conversion was observed from 80 °C to 100 °C but after heating at 
135 °C, decomposition occurred. 
 
  
At this time, the malonate addition to quinone 66 had just been achieved (Scheme 
76), thereby making the C8a-C9 bond. Further attempts to couple the amine (165) to the 
quinone malonate (185) had resulted in decomposition. The goal now shifted to amine 
addition first followed by malonate addition. To that end, aminoquinone 169 was treated 
with diethylmalonate and sodium hydride in THF. While every other reaction on the 
Scheme 79. Claisen Rearrangement of N-Allylated Aminoquinone 
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aminoquinone had resulted in complex mixtures, this reaction proceeded cleanly to give a 
single product. Unfortunately, the addition occurred at C7, not C8a.  
 
  
This clearly indicated that aminoquinone 169 was not electronically suitable for 
the desired Michael addition. Prior expectation that the C5 carbonyl system would be the 
better Michael acceptor than the C8 system was correct, though the predicted site of 
addition was at C8a, not C7. We expected the electron donation from the amine to be 
counteracted by the bromine, while on the other side, the methoxide was a fairly good 
electron donating group and the methyl group would slightly increase the alkene electron 
density as well. In addition, the methoxide is not as good a leaving group as the bromide, 
and it was deduced that while the addition might be competitive, C8a should be favored. 
However, no desired regioisomer was evident in the 
1
H NMR spectrum of the reaction.  
 Investigations thus far have revealed that a) the optimal order of addition is 
aziridinyl amine to quinone followed by C9-10 addition, b) diethyl malonate is a suitable 
C9-10 unit for the Michael addition to the aminoquinone, and c) while we have achieved 
coupling of the amine and quinone, as well as addition of C9-10, the regioselectivity of 
the addition needs to be reversed from C7 to C8a. In order to fix the regioselectivity, the 
two solutions proposed are: a) substitution (protection) of the amine nitrogen with an 
electron-withdrawing group, or b) the replacement of the bromide with the more 
Scheme 80. Malonate Addition to the Aminoquinone 
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electronegative fluoride. Both of these options should make the C8a more electrophilic 
and are discussed below.  
II. Modification of the Aminoquinone Regioselectivity: Amine Protection 
Carbamates, imides and sulfonamides are among common electron-withdrawing 
protecting group choices for amino groups. Treatment of aminoquinone 169 with tosyl 
chloride either gave no reaction with potassium carbonate in THF at reflux, or resulted in 
decomposition with potassium hydroxide in DME and sodium hydride in THF.
152
 
Previously, N-allylation had occurred with allyl bromide and potassium carbonate in 
DMF implying that the nitrogen was sufficiently nucleophilic to react with electrophiles. 
Acknowledging that the sterics of tosyl chloride may diminish its reactivity, we tried 
benzyl and phenyl isocyanate. Refluxing the aminoquinone with the isocyanate in 
chloroform or toluene, with and without pyridine, gave no reaction.
153
 Deprotonation 
with sodium hydride in THF at 0 °C followed by addition of the isocyanate to the 
deprotonated amine 169 gave complex mixtures by 
1
H NMR.
154
  
The Boc group was then considered, since despite its sterically hindered nature, 
its otherwise high reactivity should assist in acylation. Addition of the aminoquinone to 
Boc-anhydride and DMAP in dichloromethane resulted in instant bubbling and a color 
change from pink to purple (aminoquinone 169 is bright pink; the color change to purple 
was observed before with NaH) (Scheme 81).
155
 The purple color dissipated in 5 min and 
the light brown reaction mixture was quenched with aqueous ammonium chloride. 
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1
H NMR analysis of the reaction mixture after work up showed a single major product 
with Boc incorporation but in the hydroquinone form (Me and OMe peaks on the 
aromatic ring are usually ~1.9-2.0 ppm and ~4.0 ppm respectively for the quinones 
prepared so far, and >2.0 ppm and ~3.7 ppm for the hydroquinones). Column 
chromatography gave a mixture of two compounds, one of which was aldehyde 189 and 
the other was the putative product with Boc incorporation but a missing N-CH2. 
Decoupling experiments showed coupling of the aziridine C-H to an imine C-H, and the 
product is proposed to be 197. The upfield aliphatic region was not clean so it was 
unclear if there were one or two Boc groups, and if they were part of the product or not. 
The presence of an imine was confirmed by complete hydrolysis to the aldehyde (189) 
upon standing in CDCl3, but the hydroquinone hydrolysis partner was not isolated due to 
its apparent instability. 
 
  
The Boc-acylation reaction was probed further discovering that the acylation did 
not occur without DMAP. The in situ reduction of putative imine 197 with sodium 
cyanoborohydride after Boc anhydride and DMAP addition resulted in a complex 
mixture with no aziridine peaks evident by 
1
H NMR. If during the reaction only one of 
the quinone oxygens (on C5) was being acylated, then it could be through an initial N-
Scheme 81. Aminoquinone Reaction with Boc-Anhydride and DMAP 
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acylation followed by Boc transfer via a 5-membered ring intermediate. In this case, a 
nucleophile in the same pot might be able to capture the N-acylated intermediate. The 
reaction was performed with the simultaneous addition of Boc2O, DMAP and 
diethylmalonate but gave no reaction in spite of adding excess reagents. Even if the 
malonate (5 equivalents) added to Boc2O (10 equivalents plus 11 equivalents DMAP), 
there was still enough reagent to produce putative product 197. 
 We believed the problem with the Boc-acylation was in the purification of the 
reaction – the putative product (197) was difficult to purify on small scale because it was 
always contaminated by some aldehyde (189), and repeated column chromatography 
resulted in complete conversion to the aldehyde. Definitive structural assignment of the 
product was hindered, precluding speculation about the mechanism for its formation. The 
experiment with diethyl malonate suggested that the Boc group was not transferred from 
the nitrogen, or that should the reaction undergo intramolecular Boc transfer, the 
malonate nucleophile was not reactive enough to perform a Michael addition into the N-
Boc intermediate. In order to achieve our goal to reverse regioselectivity, it was 
important to know if both quinone oxygens were acylated as this implied that the nitrogen 
was not competitive toward acylation under these conditions to give the desired N-EWG 
aminoquinone. For this reason, another protecting group was sought which might be 
easier to separate from aldehyde 189 and if not, at least provide more information 
concerning the product by 
1
H NMR analysis. The Cbz group was chosen because its 
benzyl peaks would not overlap with any of the starting material or aldehyde peaks 
(
1
H NMR).  
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 The aminoquinone (169) did not react with benzyl chloroformate in 
dichloromethane, nor did it react with benzyl chloroformate in the presence of DMAP 
and diisopropyl ethylamine in chloroform at reflux.
156
 Sodium hydride deprotonation 
followed by benzyl chloroformate yielded a single major product by 
1
H NMR, similar to 
197, which had an imine and two benzyl CH2 peaks (Scheme 82).
157,158
 Column 
chromatography afforded 198 in a very low yield (3%), which hydrolyzed to the aldehyde 
on standing within a few hours. LCMS of this sample showed a major peak at 516, which 
corresponds to the hydrolyzed hydroquinone partner with two Cbz groups (199), and a 
small peak corresponding to imine 198. Another peak was observed at 472 (also with 
bromine isotope pattern) but was not identified. 
 
  
The formation of imine 198 is proposed to occur as follows (Scheme 83). Sodium 
hydride deprotonates the amine, and the resulting anion 200 (similar to 4-pyridone anions 
that are well known for their ambident nucleophilicity)
159,154
 adds to benzyl 
chloroformate via the oxygen to give intermediate 201. [1,3]-Hydride transfer 
                                                 
156
 CbzCl, DMAP, DIPEA: Siddiqui A, Dai C, Mansoor U, Yang L, Vitharana L, Angeles A. 
Spirocondensed 1,3,4-thiadiazole derivatives for inhibiting KSP kinesin activity. WO 2009/052288. 
157
 Shintani, R.; Yamagami, T.; Kimura, T.; Hayashi, T. Org. Lett. 2005, 7, 5317-5319.  
158
 Rotzoll, S.; Reinke, H.; Fischer, C.; Langer, P. Synthesis 2009, 69-78. 
159
 Pyridone anion ambident reactivity: Breugst, M.; Mayr, H. J. Am. Chem. Soc. 2010, 132, 15380-15389. 
Scheme 82. Aminoquinone Reaction with Benzyl Chloroformate 
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(reminiscent of 192, Scheme 78), followed by tautomerization to enol 202, which will be 
deprotonated under basic conditions and can then add to benzyl chloroformate giving 
observed product 198.    
 
 
Now that it is clear that O-acylation of the aminoquinone (169) occurs before N-
acylation, the regioselectivity switch from C7 to C8a of the aminoquinone (169) cannot 
be executed by decreasing the electron-donating power of the amine, but instead needs to 
be done by amplifying the electron-withdrawing power of the other substituent. 
III. Modification of the Aminoquinone Regioselectivity: Fluoride Substitution 
Fluoride replacement of the bromide should make the C8a addition site more 
electrophilic than the C7 site. The fluorine needs to be installed prior to the coupling of 
the quinone and the amine (Scheme 84). If the coupling proceeded as before, then the 
malonate addition should result at the desired fluorinated position. An unknown is the 
effect of fluorine on the regioselectivity of the first Michael addition. In the event that 
Scheme 83. Proposed Mechanism of Formation of Bis(Cbz)-198 
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amine addition at the undesired carbon predominates, a solution would be to make the 
difluorinated quinone, which should mimic the regioselectivity of the dibromoquinone 
(44, Scheme 21).  
 
 
Both nucleophilic and electrophilic sources of fluorine were investigated. 
Nucleophilic fluoride addition to bromomethoxyquinone 80 were unsuccessful with 
potassium fluoride in DMSO,
160
 potassium fluoride and 18-crown-6 in acetonitrile,
161
 
silver fluoride in dioxane,
162
 and cesium fluoride in DMF. Fluoride addition to 
unsubstituted quinone 78 with potassium fluoride in DMSO was also unsuccessful. 
Hydroquinone 154 was then treated with Selectfluor, but gave direct oxidation to 
the quinone without any fluorine addition.
163
 N-Fluorobenzene succinimide (NFSI) is a 
milder reagent that has been shown to fluorinate phenols and o-hydroquinones with little 
or no oxidation. However, the electron rich nature of 154 may have promoted oxidation 
                                                 
160
 Pei, W.; Yang, W. Synth. Commun. 2010, 40, 535 - 539. 
161
 Cameron, D.; Feutrill, G.; Griffiths, P.; Richards, K. Aust. J. Chem. 1982, 35, 1509-1512. 
162
 Feiring, A. E.; Sheppard, W. A. J. Org. Chem. 1975, 40, 2543-2545. 
163
 Nyland, R. L.; Luo, M.; Kelley, M. R.; Borch, R. F. J. Med. Chem. 2010, 53, 1200-1210. 
Scheme 84. Fluoride-Directed Addition Strategy 
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over fluorination.
164
 Since dibromoquinone 44 is prepared by bromination of the 
hydroquinone without concomitant oxidation (Scheme 20), hydroquinone 154 was treated 
with 1 equivalent NBS in dichloromethane with the expectation that mono-bromination 
would reduce the propensity to oxidize with fluoronium reagents in the next step. The 
monobromo hydroquinone was not stable to column chromatography so NFSI was added 
to the reaction after NBS but the quinone was still obtained.   
Methylated hydroquinones have been fluorinated with Selectfluor in good yield, 
so hydroquinone 154 was methylated using dimethyl sulfate and potassium carbonate in 
acetone.
155,163
 Treatment of the dimethylated hydroquinone with Selectfluor gave a 
mixture of several compounds, most of which looked to be quinone regioisomers. A 
possible fluorinated hydroquinone was isolated in 7% yield.
165
 Treatment with NBS, 
however, resulted in complete decomposition. 
It seemed that fluoro-(hydro)quinones were less stable than the bromo compounds 
previously prepared. As a result, bromination was performed first. Previously, 
fluorination of the hydroquinone (154) and monobromo hydroquinones had resulted in 
oxidation without fluorination. This time, the hydroquinone was methylated and 
brominated, so the propensity to oxidize should be further reduced. Bromination with 
NBS in CDCl3-DMSO was observed by 
1
H NMR after which NFSI was added. The 
reaction was heated at 60 °C but no fluorination occurred. The same results were 
obtained with NFSI in dioxane at reflux (101 °C); NFSI decomposes at 110 °C, so the 
reaction was not heated further. Apparently, methylation and bromination of the 
hydroquinone had significantly reduced its reactivity toward NFSI, so Selectfluor was 
                                                 
164
 Andreev, R.; Borodkin, G.; Shubin, V. Russian Journal of Organic Chemistry 2009, 45, 1468-1473. 
165
 Fluorine peak observed at –130 ppm in 19F NMR. 
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used instead. The reaction was performed in DMSO and heated but Selectfluor 
decomposed in DMSO at ~75 °C with no consumption of starting material. Propionitrile 
was used instead and gave mostly oxidation with some unreacted starting material. 
Clearly, an alternate approach to synthesizing the fluoro-(hydro)quinones is 
needed. One such approach would install the fluorine using a diazonium salt obtained by 
reduction and diazotization of the nitro-hydroquinone, and shall be investigated in the 
future.  
 
2.10. Conclusions and Future Directions 
 The installation of C10 on an advanced intermediate has been achieved using 
lithium-halogen exchange, thereby completing the carbon framework for MMC. Despite 
an undesired phenol reprotection, the vinylogous carbamate and the phenol carbonate of 
intermediate 97 can be reduced to the alcohol and phenol respectively (Scheme 85). 
Oxidative cleavage of the aziridine DPM group, and oxidation of the hydroquinone to the 
quinone with concomitant N,O-ketal opening should result in Michael addition of the free 
aziridine into the quinone, to form compound 203. Conversion of the alcohol to the 
carbamate using Kishi’s conditions,34 followed by reduction to the hydroquinone should 
result in a reduced isomitomycin intermediate 204 analogous to that in Fukuyama’s 
route.
37
 Protonation and trapping of the iminium with methanol, and subsequent 
oxidation would give mitomycin A (1), which upon ammonolysis would afford MMC 
(3). 
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Installation of C10 prior to the coupling reaction was also accomplished (Scheme 
86). The resulting spiroketal 116 contained an unfunctionalized methyl C10 and while it 
could be utilized to develop an analog of MMC, achieving the synthesis of MMC entailed 
functionalizing C10 prior to the coupling. Thus, the benzyloxyalkynyl amine 122 was 
synthesized but standard mercury-catalyzed coupling was not fruitful. Cyclization was 
achieved using pyridinium tribromide and produced dibromoimine 141. Due to the 
relative instability of the dibromoimine and steric congestion at its reactive center, most 
coupling conditions resulted in decomposition and the coupling was not achieved. This 
necessitated the addition of the amine moiety of the aziridine fragment to the quinone 
prior to cyclization. 
 
Scheme 85. Proposed Completion of Mitomycin C using Vinylogous Carbamate 97 
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The requisite aminoquinone 169 was successfully synthesized from amine 165 
and quinone 80 (Scheme 87). Since the Michael addition of the last two carbons of MMC 
(C9, C10) on 169 produced the undesired regioisomer, the corresponding fluoro-
aminoquinone 207 will be prepared. The electronegativity of the fluorine should direct 
the substitution to give the desired regioselectivity. The Michael addition product 208 
will then be subjected to an intramolecular cyclization to the eight-membered ring 
intermediate 209.
166,167
 Following protection of the ketone, the C10 alcohol will be 
obtained by decarboxylation and reduction of the ester to the alcohol. Since the reduction 
will also reduce the quinone, air oxidation will generate 210, which is similar to an 
intermediate in Kishi’s synthesis (16, Scheme 1).34 Following Kishi’s protocol, 
                                                 
166
 Malonate intramolecular cyclization onto ester: Dominguez, J. N.; Zapata, A. J.; Lobo, G. M.; Blanca, I. 
Pharmazie 1995, 50, 337-341. 
167
 Malonate intramolecular cyclization onto ester: Sedelmeier, G.; Mickel, S. J.; Rueeger, H. (Novartis A. 
–G.; Novartis Pharma G.m.b.H). Process for alternative synthesis of aliskiren and intermediates. WO 
2006024501, August 30, 2005. 
Scheme 86. Overview of C10 Installation Prior to Coupling 
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unmasking the dimethyl ketal and cyclization with tetrafluoroboric acid, followed by 
carbamoylation, ammonolysis and deprotection of the aziridine will furnish MMC. 
 
 
  
Scheme 87. Proposed Completion of MMC using Aminoquinone 207 
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Chapter 3 
 
Experimental Section 
 
 All reagents and solvents were commercial grade and purified prior to use when 
necessary. Toluene, dichloromethane, acetonitrile and benzene were dried by passage 
through a column of activated alumina as described by Grubbs.
168
 Thin layer 
chromatography (TLC) was performed using glass-backed silica gel (250 μm) plates and 
flash chromatography utilized 230–400 mesh silica gel from Sorbent Technologies. UV 
light, and/or the use of potassium iodoplatinate, ninhydrin, ceric ammonium molybdate 
and potassium permanganate solutions were used to visualize products. Anhydrous 
magnesium sulfate was used to dry organic solutions unless otherwise specified. 
 Nuclear magnetic resonance spectra (NMR) were acquired on a Bruker DRX-500 
(500 MHz), Bruker AV-400 (400 MHz) or Bruker AV II-600 (600 MHz) instrument. 
Chemical shifts are measured relative to residual solvent peaks as an internal standard set 
to δ 7.26 and δ 77.16 (CDCl3). IR spectra were recorded on a Thermo Nicolet IR100 
spectrophotometer and are reported in wave numbers (cm
-1
). Compounds were analyzed 
as neat films on a NaCl plate (transmission) or as a solution in chloroform. Mass spectra 
were recorded on a Thermo Electron Corporation MAT 95XP-Trap mass spectrometer by 
use of chemical ionization (CI), electron impact ionization (EI) or electrospray ionization 
(ESI) by the Indiana University Mass Spectrometry Facility, or on a Synapt hybrid 
quadrupole/oa-TOF mass spectrometer equipped with a dual chemical 
                                                 
168
 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 
15, 1518-1520. 
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ionization/electrospray (ESCI) source by Vanderbilt University Mass Spectrometry 
Facility. 
 
 
Compound 97. To a solution of the bromide (20.0 mg, 26.3 μmol) in THF (0.5 mL) at 
−78 °C was added nBuLi (47.0 μL, 117.5 μmol, 2.5M in hexanes). The reaction was 
stirred for 5 min, and then methyl chloroformate was added (50.0 μL, 64.7 μmol) at 
−78 °C. The reaction was allowed to warm to room temperature over 30 min and then 
concentrated. Column chromatography (neutral Al2O3, 0-20% ethyl acetate in hexanes) 
afforded the title compound (6.0 mg, 33%). Rf = 0.11 (20% EtOAc/hexanes); IR (film) 
1763, 1701, 1255, 1130, 1040 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.60 (d, J = 7.3 Hz, 
2 H), 7.55 (d, J = 6.7 Hz, 2 H), 7.39 (d, J = 7.2 Hz, 2 H), 7.35 (t, J = 7.6 Hz, 3 H), 7.23-
7.29 (m, 9 H), 7.18 (t, J = 7.4 Hz, 2 H), 6.41 (s, 1 H), 3.87 (s, 3 H), 3.80 (s, 3 H), 3.75 (s, 
1 H), 3.30 (d, J = 5.1 Hz, 1 H), 3.15 (dd, J = 11.0, 3.8 Hz, 1 H), 3.08 (d, J = 10.9 Hz, 
1 H), 3.06 (s, 3 H), 2.54 (dd, J = 5.0, 3.8 Hz, 1 H), 1.97 (s, 3 H); 
13
C NMR (150 MHz, 
CDCl3) ppm 170.3, 153.8, 150.8, 147.6, 145.9, 144.8, 143.3, 142.7, 142.3, 139.1, 128.6, 
128.5(3C), 128.4, 128.4, 128.1, 127.8, 127.8, 127.2, 127.1(3C), 127.1(3C), 127.1, 126.4, 
120.1, 114.6, 104.3, 97.9, 75.0, 61.0, 56.0, 55.2, 50.9, 50.0, 40.1, 9.2; HRMS (ESI): 
Exact mass calcd for C43H39O7N2 [M+H]
+
 695.2757, found 695.2759.  
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Structural Elucidation for Tetracyclic Vinylogous Carbamate 97 
Key Features 
The structure was assigned as the vinylogous carbamate using standard 1D and 2D NMR 
techniques. 
1
H NMR indicated the presence of two new singlets integrating to 3H each, at 
3.06 and 3.80 ppm, assigned as CH3O- fragments. The absence of a deshielded 
(8.13 ppm) doublet associated with the benzoyl group in the vinyl bromide starting 
material indicated that the phenol had been deprotected. The absence of an alcohol proton 
(by 
1
H and IR), and the presence of the second methyl group at 3.80 ppm suggested 
reprotection of the phenol as its methyl carbonate. 
13
C NMR clearly indicated the 
presence of an ester at 170.3 ppm and a carbonate at 153.8 ppm. HMBC showed a strong 
3
JHC between H16 (3.06 ppm) and C15 (170.3 ppm) which confirmed assignment of the 
methyl ester (vinylogous carbamate). A strong 
3
JHC between H18 (3.80 ppm) and C17 
(153.8 ppm) confirmed the assignment of the methyl carbonate. The methyl carbonate 
could be further distinguished from the aryl methyl ether (3.87 ppm) by the ether’s strong 
3
JHC to C6 (150.8 ppm) combined with the strong 
3
JHC for H7 (1.97 ppm) to C6. 
Additional corroborating evidence included: 1) absence of H9 observed at 5.23 ppm in 
the starting material, 2) conservation of H3 at 6.41 ppm. The remaining structure 
assignment was straightforward, relying on chemical shifts and couplings by 
1
H NMR, in 
combination with the HSQC experiment. IR confirmed the presence of a conjugated ester 
C=O at 1700 cm
-1
 and a carbonate C=O at 1763 cm
-1
.  
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Additional Features 
The proton at 6.41 ppm was 
assigned to aromatic proton H3 on 
the basis of strong HMBC 
correlations to C9, C4 
(144.8 ppm), C5 (120.1 ppm) and weak correlations to C7 (9.2 ppm) were the key 
correlations used to assign 6.41 ppm as H3 and not H9.  
13
C assignments at quaternary carbons C2, C9 and C11 could be established by HMBC 
correlations from H13 (3.08 ppm) to C10 (147.6 ppm) and from H11 (3.30 ppm, weak) to 
C10. The 
13
C shifts are as expected for an enamine and a conjugated ester,
169
 and a 
vinylogous carbamate,
170
 with C9 shifted substantially upfield from C10. The general 
trend for the 
13
C shifts compared well to those of compound 95 and the benzoyl-protected 
unsubstituted enamine 92.  
The rest of the molecule is relatively unchanged by comparison to precursors. 
1
H NMR 
showed, and HMBC confirmed, that the aziridine and amine were intact (with expected 
chemical shifts, splitting patterns and coupling constants). This indicates that it is highly 
unlikely that the amine or aziridine nitrogens were acylated. 
1
H NMR indicated presence 
of all diphenyl methyl protons as well as methine H14 at 3.75 ppm. HMBC correlations 
from H14 to 142.7, 143.3 and protons between 127.05-127.11 ppm and a correlation from 
7.39 ppm to C14 (75.9 ppm) confirmed that the aziridinyl diphenyl methyl group was still 
present. The key correlation that established the presence of the N,O-ketal diphenyl 
groups was an HMBC correlation from aromatic protons at 7.55 ppm to C19 (97.9 ppm). 
                                                 
169
 Pretsch, E.; Bühlmann, P.; Affolter, C. Structure Determination of Organic Compounds; 3 ed.; Springer: 
New York, 2000.  
170
 Ramtohul, Y. K.; Chartrand, A. Org. Lett. 2007, 9, 1029-1032. 
13
C NMR taken in acetone-d6. 
Figure 8. Key HMBC Correlations for 97 
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Compound 100. To a solution of the phenol (18.0 mg, 31.1 μmol) in anhydrous DMF 
(100 μL) at 0 °C was added NaH (4.1 mg, 160 μmol), followed by PMBCl (6.0 μL, 
44 μmol). The reaction mixture was stirred for 30 min at 0 °C. The solution was allowed 
to warm to room temperature and stirred for an additional 15 min. The reaction was 
quenched with water and then stirred vigorously. The aqueous layer was extracted with 
ethyl acetate. The combined organic layers were washed with water, brine and then dried, 
filtered and concentrated. The crude product was purified via column chromatography 
(neutral alumina, 0-20% ethyl acetate in hexanes) to afford the title compound (7.3 mg, 
35%). Rf = 0.39 (20% EtOAc/hexanes); IR (film) 1652, 1602, 1515, 1492, 1468, 1451, 
1432, 1249, 1109, 1030 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.78 (b, 2H), 7.65 (d, J = 
7.3 Hz, 2 H), 7.49 (d, J = 7.2 Hz, 2 H), 7.42 (t, J = 7.4 Hz, 3 H), 7.24-7.36 (m, 13 H), 
6.92 (d, J = 8.7 Hz, 2 H), 6.18 (s, 1 H), 5.36 (s, 1 H), 4.81 (dd, J = 15.0, 11.1 Hz, 2 H), 
3.95 (s, 3 H), 3.84 (s, 3 H), 3.79 (s, 1 H), 3.22 (dd, J = 10.6, 3.4 Hz, 1 H), 3.15 (d, J = 
10.6 Hz, 1 H), 3.00 (d, J = 5.1 Hz, 1 H), 2.64 (dd, J = 5.0, 3.4 Hz, 1 H), 2.13 (s, 3 H); 
13
C NMR (100 MHz, CDCl3) ppm 159.1, 152.3, 150.7, 143.9, 143.8, 143.4, 143.3, 141.7, 
139.8, 129.8, 128.9, 128.5, 128.1, 128.0, 127.9, 127.7, 127.7, 127.4, 127.2, 127.1, 127.0, 
116.1, 113.7, 106.3, 98.3, 96.5, 74.7, 70.0, 60.9, 55.5, 50.3, 41.4, 9.2; HRMS (ESI): 
Exact mass calcd for C47H43O4N2 [M+H]
+
 699.3196, found 699.3220.  
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Compound 101. To a solution of the enamine (150.0 mg, 226.1 mmol) in CH2Cl2 
(4.6 mL) at rt was added NBS (48.0 mg, 269.7 mmol). The reaction mixture was stirred 
for 20 min and then concentrated. Column chromatography (neutral alumina, 0-20% 
ethyl acetate in hexanes) afforded the desired bromoenamine (112.1 mg, 64%). Rf = 0.40 
(20% EtOAc/hexanes); IR (film) 1594, 1514, 1449, 1406, 1248, 1124, 702 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.59 (d, J = 7.5 Hz, 2 H), 7.45 (d, J = 7.4 Hz, 2 H), 7.37 (t, 
J = 7.6 Hz, 3 H), 7.26-7.31 (m, 10 H), 7.17-7.23 (m, 5 H), 6.87 (d, J = 5.9 Hz, 2 H), 6.86 
(s, 1 H), 4.82 (s, 2 H), 3.87 (s, 3 H), 3.85 (s, 1 H), 3.81 (s, 3 H), 3.70 (d, J = 5.1 Hz, 1 H), 
3.25 (d, J = 10.7 Hz, 1 H), 3.19 (dd, J = 10.7, 3.6 Hz, 1 H), 2.56 (dd, J = 4.7, 4.0 Hz, 
1 H), 2.04 (s, 3 H); 
13
C NMR (150 MHz, CDCl3) ppm 159.1, 152.1, 150.5, 144.0, 143.3, 
143.2, 142.8, 140.9, 138.9, 129.6, 129.1, 128.8, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 
127.7, 127.7, 127.5, 127.4, 127.3, 127.2, 127.0, 117.5, 113.7, 108.9, 97.4, 93.7, 74.7, 
70.0, 60.9, 56.5, 55.2, 53.7, 40.6, 9.0; HRMS (ESI): Exact mass calcd for C47H42O4BrN2 
[M+H]
+
 777.2301, found 777.2325.  
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(E)-Methyl 6-benzhydryl-2-(7-methoxy-5-((4-methoxybenzyl)oxy)-6-methyl-2,2-
diphenylbenzofuran-3(2H)-ylidene)-3,6-diazabicyclo[3.1.0]hexane-3-carboxylate 
(103). To a solution of the bromide (48.0 mg, 61.7 μmol) in THF (4.2 mL) at −78 °C was 
added 
n
BuLi (60.0 μL, 149 μmol, 2.49 M in hexanes). The reaction was stirred for 5 min, 
and then allowed to warm to 0 °C and stirred for an additional 1.5 h at 0 °C. The reaction 
was cooled to −78 °C, and nBuLi (62.0 μL, 154 μmol, 2.49 M in hexanes) was added. 
The reaction was allowed to warm to 0 °C and stirred for an additional 1.5 h. Methyl 
chloroformate (30.0 μL, 388 μmol) was added, and the reaction was stirred at rt for an 
additional 1 h and concentrated. Column chromatography (neutral alumina, 0-20% ethyl 
acetate in hexanes) afforded the title compound as a pale yellow foam (17.5 mg, 37%). Rf 
= 0.19 (20% EtOAc/hexanes); IR (film) 1769, 1614, 1515, 1454, 1265, 1220, 1119 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.33 (d, J = 3.1 Hz, 2 H), 7.31 (d, J = 7.8 Hz, 2 H), 7.11-
7.30 (m, 16 H), 7.10 (d, J = 4.1 Hz, 2 H), 6.94 (d, J = 8.6 Hz, 2 H), 6.62 (s, 1 H), 4.86 (s, 
2 H), 3.83 (s, 3 H), 3.80 (s, 1 H), 3.76 (s, 3 H), 3.74 (s, 3 H), 3.61 (dd, J = 6.4, 5.9 Hz, 
2 H), 2.50 (dd, J = 6.1, 5.9 Hz, 1 H), 2.46 (d, J = 6.1 Hz, 1 H), 2.17 (s, 3 H); 
13
C NMR 
(150 MHz, CDCl3) ppm 159.4, 154.9, 153.6, 150.7, 142.7, 142.4, 139.7, 132.4, 130.0, 
128.8, 128.3, 128.2, 127.9, 127.9, 127.8, 127.3, 127.2, 122.8, 114.8, 114.0, 110.6, 91.2, 
77.9, 70.3, 61.0, 55.6, 55.3, 54.0, 47.0, 33.8, 9.5; HRMS (ESI): Exact mass calcd for 
C49H45O6N2 [M+H]
+
 757.3278, found 757.3279.  
Structural Elucidation for Carbamate 103 
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Key Features 
The structure was assigned using standard 1D and 2D NMR techniques. The presence of 
the C17 carbamate was evident from 
13
C NMR (153.6 ppm) and IR (carbonyl at 1769 cm
-
1
). A singlet, integrating to 3H, at 3.80 ppm, was assigned as the carbamate (H18) due to 
a strong HMBC 
3
JCH correlation to C17 (153.6 ppm). The methyl carbamate was 
distinguished from the aryl methyl ether (3H at 3.76 ppm) by a strong HMBC correlation 
to C7 (150.7 ppm); this assignment was confirmed by an HMBC correlation between the 
methyl at C6 (3H at 2.17 ppm) and C7 (150.7 ppm). It was further distinguished from the 
PMB methyl ether (H16, 3.74 ppm) which showed an HMBC correlation to C15 
(159.4 ppm), and was assigned based on HMBC correlations between H14 (6.94 ppm) 
and C15 (159.4 ppm). Enamine carbon C9a (139.7 ppm) was tentatively assigned using 
HMBC correlations from H3 (3.61 ppm), and H4a (6.62 ppm); enamine carbon C10 
using HMBC correlations from H1 (2.46 ppm) and H4a (6.62 ppm); diphenylcarbon C11 
using H1 (2.46 ppm). 
Additional Features 
The aromatic carbons were assigned 
based on 
13
C NMR and HMBC 
correlations with the C6 methyl and 
H4a, and these were in agreement with 
precursor compounds; the aziridine 
and pyrrolidine moieties were assigned 
based on 
13
C NMR, coupling from 
1
H NMR, and HMBC correlations.  
Figure 9. Key Correlations for Carbamate 103 
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(E)-6-Benzhydryl-N-benzyl-2-(7-methoxy-5-((4-methoxybenzyl)oxy)-6-methyl-2,2-
diphenylbenzofuran-3(2H)-ylidene)-3,6-diazabicyclo[3.1.0]hexane-3-carboxamide 
(105). To a solution of the carbamate (8.5 mg, 11 μmol) in THF (0.4 mL) at rt, lithium 
aluminum hydride (0.7 mg, 18 μmol) was added. The reaction was stirred for 1 h and 
then lithium aluminum hydride (2.0 mg, 53 μmol) was added. After TLC showed 
complete consumption of starting material, the reaction was quenched with aq. KF. The 
aqueous layer was extracted with ethyl acetate. The organic layers were dried, filtered 
and concentrated to afford the crude amine (7.2 mg). To a solution of the crude amine in 
THF at rt was added benzyl isocyanate (4.5 μL, 36 μmol) and pyridine (3.0 μL, 37 μmol). 
The reaction mixture was stirred for 2 d and then concentrated. Column chromatography 
(neutral alumina, 20-50% ethyl acetate in hexanes) afforded the title compound (5.3 mg, 
50% over two steps). Rf = 0.10 (20% EtOAc/hexanes); IR (film) 3414, 2925, 1746, 1515, 
1454, 1249, 1117 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.48 (d, J = 7.6 Hz, 2H), 7.38-7.31 
(m, 10H), 7.28-7.18 (m, 8H), 7.06 (b, 2H), 6.94 (d, J = 8.6 Hz, 2H), 6.64 (s, 1H), 5.25 (b 
dd, J = 5.9, 5.8 Hz, 1H), 4.89 (s, 2H), 4.34 (dd, J = 14.9, 6.4 Hz, 1H), 4.22 (dd, J = 15.6, 
5.8 Hz, 1H), 3.84 (s, 3H), 3.81 (s, 1H), 3.75 (s, 3H), 3.61 (b, 2H), 2.45 (b, 1H), 2.31 (d, J 
= 5.3 Hz, 1H), 2.18 (s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 159.6, 154.8, 154.4, 
151.7, 142.8, 142.6, 141.3, 139.9, 138.6, 130.0, 129.1, 129.1, 128.7, 128.7, 128.6, 128.5, 
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128.3, 128.2, 128.0, 127.9, 127.7, 127.6, 127.6, 127.4, 127.2, 122.9, 115.6, 114.1, 110.7, 
90.9, 78.0, 70.6, 61.0, 55.5, 54.2, 47.0, 45.4, 34.1, 9.7; HRMS (ESI): Exact mass calcd 
for C55H50O5N3 [M+H]
+
 832.3745, found 832.3644. 
 
 
Compound 110. To a solution of the alkynyl amine (152.0 mg, 354.7 μmol) in THF 
(1.5 mL) at rt was added HgCl2 (48.1 mg, 177 μmol) and triethylamine (300 μL, 
2 mmol). The reaction mixture was stirred for 4 h and then the quinone (92.8 mg, 
355 μmol) was added. The reaction mixture was stirred overnight, and then filtered 
through a pad of celite and concentrated to provide the crude phenol as a brown oil. To a 
solution of the crude phenol in CH2Cl2 (3.0 mL) at 0 °C was added triethylamine 
(100 μL, 700 μmol) and tosyl chloride (93.2 mg, 489 μmol). The reaction mixture was 
allowed to warm to rt and stirred for an additional 1 h at rt. Triethylamine (300 μL, 
2 mmol) was added, and then the reaction mixture was stirred for an additional 4 h and 
concentrated. Column chromatography (neutral alumina, 5-40% ethyl acetate in hexanes) 
afforded the tosylated phenol as a white foam (42.3 mg, 18% over 2 steps). Rf = 0.15 
(20% EtOAc/hexanes); IR (film) 3061, 2930, 1650, 1451, 1371, 1191, 1067 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.58 (d, J = 7.5 Hz, 2H), 7.47 (d, J = 8.2 Hz, 2H), 7.43 (d, 
J = 7.4 Hz, 2H), 7.40 (dd, J = 7.7, 7.6 Hz, 3H), 7.31-7.25 (m, 10H), 7.23 (d, J = 7.5 Hz, 
2H), 7.21 (d, J = 8.2 Hz, 3H), 6.30 (s, 1H), 5.12 (s, 1H), 3.83 (s, 3H), 3.76 (s, 1H), 3.18 
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(dd, J = 10.6, 3.5 Hz, 1H), 3.07 (d, J = 10.6 Hz, 1H), 2.95 (d, J = 5.0 Hz, 1H), 2.62 (dd, J 
= 4.6, 3.9 Hz, 1H), 2.43 (s, 3H), 1.75 (s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 150.7, 
146.3, 145.0, 144.8, 143.3, 143.3, 143.2, 139.5, 132.8, 129.6, 129.1, 128.1, 128.7, 128.7, 
128.6, 128.6, 128.4, 128.2, 128.1, 127.9, 127.5, 127.4, 127.3, 127.1, 120.4, 116.4, 97.7, 
97.3, 74.8, 61.0, 55.7, 50.2, 41.4, 21.5, 9.8; HRMS (CI): Exact mass calcd for 
C46H41O5N2S [M+H]
+
 733.2731, found 733.2704. 
 
 
Compound 111. To a solution of the enamine (37.1 mg, 50.6 μmol) in CH2Cl2 (1.0 mL) 
at rt was added N-bromosuccinimide (9.7 mg, 54.5 μmol). The reaction mixture was 
stirred for 10 min and then concentrated. Column chromatography (neutral alumina, 0-
20% ethyl acetate in hexanes) afforded the title compound as a white foam (26.5 mg, 
65%). Rf = 0.30 (20% EtOAc/hexanes); IR (film) 2926, 1595, 1449, 1404, 1372, 1190, 
1178 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.56 (d, J = 7.3 Hz, 2H), 7.46-7.43 (m, 5H), 
7.37 (dd, J = 7.8, 7.6 Hz, 3H), 7.31-7.27 (m, 7H), 7.23-7.18 (m, 7H), 6.56 (s, 1H), 3.86 
(s, 3H), 3.84 (s, 1H), 3.62 (d, J = 5.1 Hz, 1H), 3.21 (d, J = 1.7 Hz, 2H), 2.56 (ddd, J = 
5.1, 2.0, 2.0 Hz, 1H), 2.40 (s, 3H), 1.97 (s, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 150.8, 
145.6, 145.1, 145.1, 143.4, 143.2, 142.9, 142.8, 138.8, 132.6, 129.7, 128.9, 128.8, 128.7, 
128.7, 128.5, 128.4, 128.1, 128.1, 127.8, 127.6, 127.4, 127.3, 122.5, 118.9, 98.0, 92.3, 
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74.8, 61.3, 56.6, 53.6, 40.6, 21.9, 10.1; HRMS (CI): Exact mass calcd for C46H40O5BrN2S 
[M+H]
+
 811.1836, found 811.1842. 
 
 
N-((1-Benzhydryl-3-(prop-1-yn-1-yl)aziridin-2-yl)methyl)-1,1-diphenylmethanamine 
(115). To a solution of the terminal alkyne (204.8 mg, 477.9 μmol) in THF (1.0 mL) at 
−78 °C was added nbutyllithium (192.0 μL, 480.0 μmol). The reaction mixture was 
stirred for 30 min at −78 °C and then methyl iodide (130 μL, 2 mmol) was added. The 
reaction mixture was allowed to warm to rt and then stirred for an additional 40 min, and 
then concentrated. Column chromatography (silica gel, 0-40% ethyl acetate in hexanes) 
afforded the title compound as a pale yellow foam (32.3 mg, 71%). Rf = 0.33 (20% 
EtOAc/hexanes); IR (film) 3303, 3026, 1599, 1493, 1452, 737, 701 cm
-1
; 
1
H NMR 
(600 MHz, CDCl3) δ 7.45 (d, J = 7.6 Hz, 2H), 7.34 (d, J = 7.2 Hz, 2H), 7.31 (dd, J = 7.8, 
7.5 Hz, 2H), 7.25-7.15 (m, 14H), 4.68 (s, 1H), 3.63 (s, 1H), 2.77 (dd, J = 12.2, 5.3 Hz, 
1H), 2.69 (dd, J = 12.2., 7.0 Hz, 1H), 2.18 (dd, J = 6.4, 1.7 Hz, 1H), 2.08-2.04 (m, 1H), 
1.77 (d, J = 0.86 Hz, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 144.2, 144.0, 143.0, 142.5, 
128.7, 128.6, 128.5, 128.4, 128.4, 128.4, 128.0, 127.9, 127.4, 127.3, 127.2, 78.1, 78.0, 
75.7, 67.2, 48.2, 44,9, 33.7, 4.0; HRMS (CI): Exact mass calcd for C32H31N2 [M+H]
+
 
443.2482, found 443.2491. 
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3',6'-Dibenzhydryl-4-bromo-7-methoxy-3,6-dimethyl-3H-3',6'-
diazaspiro[benzofuran-2,2'-bicyclo[3.1.0]hexan]-5-ol (116). To a solution of the 
alkynylamine (24.6 mg, 55.6 μmol) in THF (300 μL) at rt was added HgCl2 (7.4 mg, 
27 μmol) and triethylamine (47.5 μL, 341 mmol). The reaction mixture was stirred for 
4 h and then the quinone (14.7 mg, 56.3 μmol) was added. The reaction mixture was 
stirred overnight, and then filtered through a pad of celite and concentrated. Column 
chromatography (neutral alumina, 0-40% ethyl acetate in hexanes) provided the title 
compound (9.0 mg, 24%). Rf = 0.42 (20% EtOAc/hexanes); IR (film) 3060, 2924, 1493, 
1452, 1424, 1102, 700 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.58 (d, J = 7.4 Hz, 2H), 7.52 
(d, J = 8.0 Hz, 2H), 7.44 (d, J = 7.1 Hz, 2H), 7.42-7.38 (m, 4H), 7.36-7.30 (m, 4H), 7.28-
7.23 (2H), 7.16-7.14 (m, 2H), 6.66 (dd, J = 8.0, 1.7 Hz, 2H), 5.24 (s, 1H), 3.75 (s, 1H), 
3.52 (s, 3H), 3.31 (d, J = 9.8 Hz, 1H), 3.13 (q, J = 7.0 Hz, 1H), 2.82 (dd, J = 9.9, 2.8 Hz, 
1H), 2.82 (d, J = 5.1 Hz, 1H), 2.40 (dd, J = 5.2, 2.6 Hz, 1H), 2.19 (s, 3H), 0.67 (d, J = 
7.0 Hz, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 144.0, 143.5, 143.2(2C), 142.4, 141.8, 
140.8, 130.3, 130.0, 128.7, 128.6, 128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 127.8, 127.1, 
127.0, 117.1, 112.0, 99.1, 74.9, 60.6, 59.4, 47.4, 41.2, 40.3, 15.6, 10.1; HRMS (ESI): 
Exact mass calcd for C40H38O3BrN2 [M+H]
+
 673.2066, found 673.2042. 
Structural Elucidation for Spiroketal 116 
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Key Features 
The structure was assigned as the spiroketal using standard 1D and 2D NMR techniques. 
1
H NMR indicated the presence of a new quartet, integrating to 1H, at 3.13 ppm (
3
JHH = 
7.0 Hz). HSQC assigned this methine to a carbon at 41.2 ppm. A doublet integrating to 
3H at 0.67 ppm (
3
JHH = 7.0 Hz) was also observed. This was assigned to the C10 methyl 
group, and established the H9-C9-C10 connectivity. Additionally, HMBC showed a 
2
JHC 
between H10 (0.67 ppm) and C9 (41.2 ppm), and between H9 (3.13 ppm) and C10 
(15.6 ppm); NOESY showed a correlation between H9 (3.13 ppm) and H10 (0.67 ppm). 
The spiroketal connectivity was established as follows: a) The presence of the C8a-C9 
bond was indicated by HMBC correlations (
3
JHC) between H9 and C4a (99.1 ppm), H9 
and C8 (143.2 ppm), H10 and C8a (130.3 ppm), and a weak 
4
JHC between H6 and C4a 
(99.1 ppm). b) The location of C9a (112.0 ppm) was deduced from its HMBC 
correlations (
3
JHC) with H10, N4-DPM methine (5.24 ppm) and both H3 protons 
(3.31 ppm, 2.82 ppm). An additional correlation was observed between C9a and H9. 
Furthermore, the 
13
C shift at 112.0 ppm was within the expected N,O-ketal carbon range 
(as observed in previous compounds). The key NOESY correlations shown in Figure 10 
indicate the anti orientation of the pyrrolidine nitrogen and the C10 methyl group. 
Additional Features 
The remaining structure assignment was 
relatively straightforward, relying on 
chemical shifts, coupling by 
1
H NMR 
and HSQC data. These assignments were 
confirmed by HMBC and NOESY correlations. All other carbon and proton shifts were 
Figure 10. Key Correlations for Spiroketal 116 
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similar to the precursor compounds. The aromatic carbons were assigned based on 
HMBC correlations to C6-methyl (2.19 ppm) and C7-methoxy (3.52 ppm). The aziridine 
and pyrrolidine moieties are relatively unchanged, as evidenced by HMBC and NOESY 
correlations, and 
1
H and 
13
C shifts. The presence of the DPM methines are deduced from 
observed HMBC correlations to the aromatic DPM groups and to the aziridine and 
pyrrolidine protons, in addition to the expected chemical shifts by 
1
H and 
13
C NMR. 
 
 
N-(4-(Benzyloxy)but-2-yn-1-ylidene)-1,1-diphenylmethanamine (124). To a solution 
of the aldehyde (526.8 mg, 3.024 mmol) and 4Å molecular sieves in diethyl ether 
(3.0 mL) at rt was added aminodiphenylmethane (0.51 mL, 2.9 mmol). The reaction 
mixture was stirred for 40 min, and then filtered and concentrated to afford the desired 
imine (1.008 g, 98%) as a mixture of the E:Z isomers in a 1:0.6 ratio. Rf = 0.47 (20% 
EtOAc/ hexanes); IR (film) 3028, 2858, 1609, 1583, 1493, 1453, 1073, 1028 739, 698 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 1.2 Hz, 0.6H), 7.74 (br s, 1H), 7.39-7.31 
(m, 19.2H), 7.29-7.23 (m, 4.8H), 6.22 (s, 0.6H), 5.52 (s, 1H), 4.64 (s, 3.2H), 4.40 (d, J = 
1.1 Hz, 1.2H), 4.36 (d, J = 0.96 Hz, 2H); 
13
C NMR (100 MHz, CDCl3) ppm 144.8, 143.1, 
142.6, 142.0, 137.1, 136.9, 128.6, 128.5, 128.5, 128.1, 127.7, 127.3, 127.2, 94.7, 89.0, 
83.8, 79.7, 78.7, 72.8, 72.0, 72.0, 57.6, 57.3. 
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N-(4-(Benzyloxy)but-2-yn-1-ylidene)-1,1-bis(4-methoxyphenyl)methanamine (129). 
To a solution of the aldehyde (510.1 mg, 2.928 mmol) and 4 Å molecular sieves in 
diethyl ether (3.0 mL) at rt was added bis(4-methoxyphenyl)methanamine (693.2 mg, 
2.849 mmol). The reaction mixture was stirred for 10 min, and then filtered and 
concentrated to afford the desired imine (1.033 g, 88%) as a mixture of the E:Z isomers in 
a 1:0.6 ratio. Rf = 0.15 (20% EtOAc/ hexanes); IR (film) 2836, 1608, 1510, 1249, 1175, 
1032 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.72 (br s, 0.6H), 7.68 (s, 1H), 7.38-7.19 (m, 
14.4H), 6.87-6.84 (m, 6.4H), 6.11 (s, 0.6H), 5.43 (s, 1H), 4.63 (s, 1.2H), 4.62 (s, 2H), 
4.39 (d, J = 1.0 Hz, 1.2H), 4.34 (d, J = 0.8 Hz, 2H), 3.79 (s, 3H), 3.78 (s, 1.8H); 
13
C NMR (100 MHz, CDCl3) ppm 144.8, 135.5, 134.9, 128.6 (2C), 128.6, 128.3, 128.0, 
126.7, 88.7, 79.6, 78.0, 72.4, 58.0, 55.7; HRMS (CI): Exact mass calcd for C26H25O3N 
[M]
+
 399.1829, found 399.1835. 
 
 
Ethyl 1-benzhydryl-3-(3-(benzyloxy)prop-1-yn-1-yl)aziridine-2-carboxylate (126). 
To a solution of the imine (21.3 mg, 62.7 μmol) in propionitrile (0.4 mL) at –78 °C was 
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added triflic acid (7.00 μL, 87.5 μmol), followed by drop-wise addition of ethyl 
diazoacetate (78.0 μL, 752 μmol). The reaction mixture was stirred for 6 h and then 
quenched with satd. aq. NaHCO3. The aqueous layer was extracted with CH2Cl2. The 
combined organic layers were dried, filtered and concentrated. Column chromatography 
(silica gel, 10% ethyl acetate in hexanes) afforded the desired cis-aziridine (9.9 mg, 
37%). Rf = 0.29 (20% EtOAc/hexanes); IR (film) 3029, 2921, 2850, 1748, 1726, 1494, 
1454, 1193, 1070 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.46 (dd, J = 7.1, 7.0 Hz, 4H), 
7.34-7.32 (m, 5H), 7.30 (dd, J = 7.6, 6.3 Hz, 4H), 7.25-7.22 (m, 2H), 4.56 (d, J = 
11.6 Hz, 1H), 4.54 (d, J = 11.6 Hz, 1H), 4.22 (dq, J = 10.9, 7.1 Hz, 1H), 4.19 (dq, J = 
10.9, 7.1 Hz, 1H), 4.18 (dd, J = 16.3, 1.5 Hz, 1H), 4.15 (dd, J = 15.9, 1.3 Hz, 1H), 3.78 
(s, 1H), 2.62 (d, J = 6.5 Hz, 1H), 2.56 (d, J = 6.5 Hz, 1H), 1.24 (t, J = 7.1 Hz, 3H); 
13
C NMR (150 MHz, CDCl3) ppm 167.4, 141.7, 137.6, 128.7, 128.7, 128.5, 128.3, 128.0, 
127.6 (2C), 127.5, 81.4, 78.7, 77.4, 71.5, 61.4, 57.6, 44.8, 34.3, 14.4; HRMS (ESI): Exact 
mass calcd for C28H28O3N [M+H]
+
 426.2069, found 426.2077. 
 
 
N-Benzhydryl-2-diazoacetamide (125). Glyoxylic acid p-tosylhydrazone, the acid 
chloride and succinimidyl diazoacetate were prepared according to previously reported 
procedure and used without purification.
105,106,107 
Benzhydryl diazoacetamide was 
prepared using literature procedure
108
 and purified using a base wash (satd. aq. NaHCO3) 
and trituration with diethyl ether to afford a yellow solid (44% over 3 steps). Rf = 0.12 
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(20% EtOAc/ hexanes); IR (film) 3250, 3089, 2100, 1604, 1541, 1371 cm
-1
; 
1
H NMR 
(600 MHz, CDCl3) δ 7.33 (dd, J = 7.6, 7.3 Hz, 4H), 7.28 (t, J = 7.3 Hz, 3H), 7.23 (d, J = 
7.3 Hz, 4H), 6.27 (br s, 1H), 5.57 (br d, J = 6.7 Hz, 1H), 4.76 (s, 1H); 
13
C NMR 
(150 MHz, CDCl3) ppm 141.6, 128.9, 127.7, 127.5, 57.5, 47.6; HRMS: decomp.  
 
 
N-((1-Benzhydryl-3-(3-(benzyloxy)prop-1-yn-1-yl)aziridin-2-yl)methyl)-1,1-
diphenylmethanamine (122). To a solution of the aldehyde (171.8 mg, 450.4 μmol) in 
THF (9.0 mL) and 4 Å molecular sieves at rt was added benzhydryl amine (70 μL, 
400 μmol). After 1 h, sodium cyanoborohydride (66.3 mg, 1.05 mmol) and acetic acid 
(27.8 μL, 485 μmol) were added. The reaction was stirred overnight at rt and then 
quenched with satd aq NaHCO3. After stirring for 1 h, the reaction mixture was filtered 
and the layers were separated. The aqueous layer was extracted with ethyl acetate. The 
organic layers were combined, dried, filtered and concentrated. Column chromatography 
(SiO2, 5-40% ethyl acetate in hexanes) afforded the amine as a yellow foam (146.7 mg, 
59%). Rf = 0.43 (20% EtOAc/ hexanes); IR (film) 3061, 3027, 2850, 1599, 1493, 1452, 
1350, 1070, 1028, 742, 700 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.51 (d, J = 7.3 Hz, 2H), 
7.40-7.32 (m, 10H), 7.26-7.18 (m, 13H), 4.70 (s, 1H), 4.57 (s, 2H), 4.17 (d, J = 1.6 Hz, 
2H), 3.71 (s, 1H), 2.84 (dd, J = 12.3 Hz, 5.1 Hz, 1H), 2.72 (dd, J = 12.2, 7.2 Hz, 1H), 
2.29 (dt, J = 6.2, 1.5 Hz, 1H), 2.19 (ddd, J = 7.0, 6.4, 5.0 Hz, 1H) [NH not observed]; 
13
C NMR (100 MHz, CDCl3) ppm 144.1, 143.9, 142.9, 142.4, 137.6, 128.7, 128.5, 128.5, 
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128.4 (2C), 128.3, 128.0 (2C), 127.7, 127.4, 127.3, 127.2 (2C), 126.9, 126.9, 83.6, 78.0, 
77.8, 71.4, 67.2. 57.6, 48.2, 45.2, 33.2; HRMS (ESI): Exact mass calcd for C39H37ON2 
[M+H]
+
 549.2906, found 549.2927. 
 
 
6-Benzhydryl-2-(2-(benzyloxy)-1,1-dibromoethyl)-3,6-diazabicyclo[3.1.0]hex-2-ene 
(141). To a solution of the amine (30.2 mg, 55.0 μmol) and potassium carbonate 
(28.1 mg, 203 μmol) in dichloromethane (1.0 mL) and water (1.0 mL) was added 
pyridinium tribromide (30.9 mg, 96.6 μmol). After 1 h at rt, a second portion of 
pyridinium tribromide (35.1 mg, 109 μmol) was added. The reaction was stirred 
overnight and then quenched with satd aq sodium sulfite. After 30 min, the layers were 
separated and the aqueous layer was extracted with ethyl acetate. The organic layers were 
combined, dried and concentrated. Column chromatography (silica gel, 10-40% ethyl 
acetate in hexanes) afforded the imine (23.1 mg, 77%). Rf = 0.28 (20% EtOAc/ hexanes); 
IR (film) 3030, 2921, 2857, 1660, 1602, 1493, 1451, 1317, 1272, 1112, 1023 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.43-7.20 (m, 15H), 4.71 (d, J = 12.6 Hz, 1H), 4.67 (d, J = 
12.4 Hz, 1H), 4.17 (d, J = 18.0 Hz, 1H), 4.11 (d, J = 11.4 Hz, 1H), 4.05 (d, J = 11.5 Hz, 
1H), 3.87 (dd, J = 18.0, 4.1 Hz, 1H), 3.63 (s, 1H), 3.48 (d, J = 2.9 Hz, 1H), 2.95 (dd, J = 
4.5, 4.0 Hz, 1H) 
13
C NMR (150 MHz, CDCl3) ppm 172.8, 142.6, 142.2, 137.6, 
128.6(2C), 128.5(2C), 128.4(2C), 128.3(2C), 127.9, 127.9(2C), 127.6, 127.3, 127.1(2C), 
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77.7, 75.4, 73.8, 62.5, 60.1, 50.7, 47.6; HRMS (ESI): Exact mass calcd for 
C26H24OBr2N2Na [M+Na]
+
 561.0153, found 561.0138. 
 
 
1-(1-Benzhydryl-3-(((diphenylmethylene)amino)methyl)aziridin-2-yl)-3-(benzyloxy)-
2,2-dibromopropan-1-one (145). To a solution of the amine (174.7 mg, 318.4 μmol) and 
potassium carbonate (218.6 mg, 1.582 mmol) in dichloromethane (3.0 mL) and water 
(3.0 mL) was added pyridinium tribromide (202.9 mg, 634.4 μmol). After 3 h at rt, a 
second portion of pyridinium tribromide (208.9 mg, 653.1 μmol) was added. The reaction 
was stirred overnight and then quenched with satd aq sodium sulfite. After 30 min, the 
layers were separated and the aqueous layer was extracted with ethyl acetate. The organic 
layers were combined, dried and concentrated. Column chromatography (silica gel, 10-
40% ethyl acetate in hexanes) afforded the title compound as a yellow oil (34.7 mg, 15%) 
and the dibromoimine (89.1 mg, 52%). Rf = 0.33 (20% EtOAc/hexanes); IR (film) 3061, 
3029, 2920, 1658, 1599, 1450, 1278 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.45-7.15 (m, 
23H), 7.05-7.02 (m, 2H), 4.59 (d, J = 12.4 Hz, 1H), 4.55 (d, J = 12.4 Hz, 1H), 4.03 (d, J 
= 11.4 Hz, 1H), 3.96 (s, 1H), 3.95 (d, J = 11.6 Hz, 1H), 3.64 (dd, J = 15.1. 5.4 Hz, 1H), 
3.46 (dd, J = 15.1, 6.8 Hz, 1H), 3.41 (d, J = 6.6 Hz, 1H), 2.96 (ddd, J = 6.4, 6.4, 5.9 Hz, 
1H); 
13
C NMR (150 MHz, CDCl3) ppm 191.8, 142.5, 142.1, 137.5, 128.7, 128.6, 128.5, 
128.5, 128.5, 128.0, 128.0, 127.9, 127.8, 127.8, 127.5, 127.4, 127.3, 78.1, 76.0, 73.8, 
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64.9, 52.6, 51.2, 45.0; HRMS (ESI): Exact mass calcd for C39H35O2Br2N2 [M+H]
+
 
721.1065, found 721.1088. 
 
 
Benzyl ((1-benzhydryl-3-(3-(benzyloxy)-2,2-dibromopropanoyl)aziridin-2-
yl)methyl)carbamate (152). To a solution of the imine (4.1 mg, 7.6 μmol) in 
dichloromethane (450 μL) was added benzyl chloroformate (2.0 μL, 14 μmol). After 
2.5 h stirring, Zn dust (2.6 mg, 39 μmol)171 was added and the reaction mixture was 
stirred overnight. Filtration and removal of the solvent afforded the ketone as a brown oil 
(2.4 mg, 47%). Rf = 0.16 (20% EtOAc/ hexanes); IR (film) 3420, 3030, 2924, 1718, 
1509, 1452, 1258, 1115 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.39-7.27 (m, 20H), 5.00 (d, 
J = 12.0 Hz, 1H), 4.93 (d, J = 12.6 Hz, 1H), 4.67 (bdd, J = 6.0, 6.0 Hz, 1H), 4.64 (s, 2H), 
4.16 (d, J = 11.4 Hz, 1H), 4.00 (d, J = 11.4 Hz, 1H), 3.87 (s, 1H), 3.34 (d, J = 6.6 Hz, 
1H), 3.28 (ddd, J = 6.6, 6.0, 2.4 Hz, 1H), 2.71 (dd, J = 6.6, 6.0 Hz, 1H), NH not observed 
13
C NMR (150 MHz, CDCl3) ppm 192.0, 156.4, 142.4, 141.6, 137.0, 136.7, 128.8 (2C), 
128.65 (2C), 128.60 (2C), 128.56 (2C), 128.2, 128.15, 128.08 (2C), 128.0 (2C), 127.9, 
127.7 (2C), 127.4, 127.2 (2C), 77.6, 76.0, 74.1, 66.7, 64.0, 49.6, 45.2, 38.7; HRMS (ESI): 
Exact mass calcd for C34H33O4Br2N2 [M+H]
+
 691.0807, found 691.0800. 
 
                                                 
171
 Zn dust was found to be unnecessary for the reaction. 
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Ethyl 3-(aminomethyl)-1-benzhydrylaziridine-2-carboxylate (165). The azide 
(31.7 mg, 94.2 μmol) and triphenylphosphine (30.2 mg, 115 μmol) were stirred in THF 
(1.9 mL) at rt overnight. Water (15 μL) was added and the reaction was stirred for a 
further 7 h. The reaction mixture was diluted with CH2Cl2, dried, filtered and 
concentrated to give a pale yellow solid. Column chromatography (silica gel, 0-10% 
methanol in dichloromethane) afforded the amine as a white solid (20.3 mg, 69%). MP Rf 
= 0.17 (10% MeOH/ dichloromethane); IR (film) 3369, 3027, 2977, 2926, 1735, 1450, 
1384, 1296, 1191, 1033, 750, 702 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.48 (d, J = 
7.4 Hz, 2H), 7.40 (d, J = 7.3 Hz, 2H), 7.30 (dd, J = 7.7, 7.6 Hz, 4H), 7.25-7.21 (m, 2H), 
4.20 (dq, J = 11.0, 7.3 Hz, 1H), 4.18 (dq, J = 10.8, 7.1 Hz, 1H), 3.74 (s, 1H), 2.84 (bdd, J 
= 13.3, 4.7 Hz, 1H), 2.79 (bdd, J = 13.1, 6.5 Hz, 1H), 2.39 (d, J = 6.7 Hz, 1H), 2.20 (ddd, 
J = 6.8, 6.8, 5.5 Hz, 1H), 2.00 (br s, 2H), 1.26 (dd, J = 7.2, 7.1 Hz, 3H); 
13
C NMR 
(150 MHz, CDCl3) ppm 169.4, 142.9, 142.1, 128.8 (2C), 128.6 (2C), 127.9 (2C), 127.8, 
127.3, 127.2 (2C), 77.7, 61.2, 47.9, 43.3, 40.4, 14.3; HRMS (CI): Exact mass calcd for 
C19H23O2N2 [M+H]
+
 311.1765, found 311.1764. 
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6-Benzhydryl-3,6-diazabicyclo[3.1.0]hexan-2-one (166). The amine (16.4 mg, 
52.8 μmol) was heated gently in deuterated chloroform in a J-Young tube until complete 
conversion achieved as determined by 
1
H NMR spectroscopy. The solvent was removed 
and the residue chromatographed (silica gel, 75% ethyl acetate in hexanes then 5-10% 
methanol in dichloromethane) to afford the lactam (11.6 mg, 83%). Rf = 0.25 (EtOAc); 
IR (film) 3227, 2921, 2852, 1699, 1449, 1063, 743, 699 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 7.43-7.40 (m, 4H), 7.34-7.28 (m, 4H), 7.27-7.20 (m, 2H), 5.52 (br s, 1H), 3.70 
(s, 1H), 3.47 (bd, J = 10.8 Hz, 1H), 3.36 (dd, J = 10.8, 3.9 Hz, 1H), 2.79 (ddd, J = 4.5, 
4.0, 1.8 Hz, 1H), 2.57 (d, J = 4.6 Hz, 1H) 
13
C NMR (125 MHz, CDCl3) ppm 174.1, 
142.6, 142.0, 128.7 (4C), 127.6, 127.5 (3C), 127.2 (2C), 75.0, 44.7, 43.0, 40.9; HRMS 
(CI): Exact mass calcd for C17H17ON2 [M+H]
+
 265.1346, found 265.1338. 
 
 
3-(Azidomethyl)-1-benzhydryl-N-methoxy-N-methylaziridine-2-carboxamide (170). 
Prepared according to literature procedure:
172
 53.6 mg (159 μmol) azidoester produced 
56.3 mg (quant.) Weinreb amide with no purification required. Rf = 0.15 (20% EtOAc/ 
hexanes); IR (film) 3029, 2928, 2855, 2097, 1667, 1451, 1333, 1182, 1109, 1011, 747, 
702 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.49 (d, J = 7.4 Hz, 2H), 7.44 (d, J = 7.3 Hz, 
                                                 
172
 Roche, C.; Labeeuw, O.; Haddad, M.; Ayad, T.; Genet, J. –P.; Vidal, V. R-; Phansavath, P. Eur. J. Org. 
Chem. 2009, 3977-3986. 
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2H), 7.33-7.28 (m, 4H), 7.24-7.18 (m, 2H), 3.83 (s, 1H), 3.53 (d, J = 6.3 Hz, 2H), 3.50 
(br s, 3H), 3.18 (s, 3H), 2.91 (br d, J = 5.4 Hz, 1H), 2.33 (dt, J = 6.4, 6.4 Hz, 1H) 
13
C NMR (125 MHz, CDCl3) ppm 168.3, 142.5, 142.3, 128.7 (2C), 128.6 (2C), 127.6 
(2C), 127.3 (2C), 127.3 (2C), 77.9, 61.5, 49.3, 44.8, 40.4, 32.6; HRMS (ESI): Exact mass 
calcd for C19H21O2N5Na[M+Na]
+
 374.1593, found 374.1577. 
 
 
Ethyl 1-benzhydryl-3-(((2-bromo-4-methoxy-5-methyl-3,6-dioxocyclohexa-1,4-dien-
1-yl)amino)methyl)aziridine-2-carboxylate (169). To amine (3.2 mg, 10.3 μmol) and 
quinone (5.6 mg, 21.4 μmol) in benzene (200.0 μL) at rt was added triethylamine (5.0 μL, 
35.9 μmol). After 2 days, the red residue was purified by column chromatography (silica 
gel, 20% ethyl acetate/hexanes) to afford the title compound as a bright pink oil (5.3 mg, 
95%). Rf = 0.21 (20% EtOAc/ hexanes); IR (film) 3321, 2923, 2853, 1735, 1657, 1587, 
1513, 1451, 1381, 1318, 1198, 1106, 1033, 701 cm
-1
; 
1
H NMR (400 MHz, CDCl3) 7.45 
(d, J = 7.4 Hz, 2H), 7.32-7.29 (m, 4H), 7.23 (d, J = 7.3 Hz, 1H), 7.19 (dd, J = 7.6, 7.2 Hz, 
2H), 7.12 (dd, J = 7.2, 7.2, 1H), 6.16 (br s, 1H), 4.22 (q, J = 7.1 Hz, 2H), 4.18 (ddd, J = 
14.5, 7.3, 5.0 Hz, 1H), 4.11 (s, 3H), 3.71 (s, 1H), 3.66 (ddd, J = 14.3, 7.0, 7.0 Hz, 1H), 
2.57, (ddd, J = 7.0, 6.9, 5.1 Hz, 1H), 2.45 (d, J = 6.5 Hz, 1H), 1.84 (s, 3H), 1.27 (t, J = 
7.1 Hz); 
13
C NMR (150 MHz, CDCl3) ppm 181.9, 175.0, 169.1, 157.4, 143.9, 142.3, 
141.9, 128.8 (2C), 128.6 (2C), 128.0 (2C), 127.7, 127.4, 127.1 (3C), 122.6, 77.9, 61.8, 
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61.5 (2C), 45.2, 43.3, 14.3, 8.7; HRMS (ESI): Exact mass calcd for C27H27O5BrN2Na 
[M+Na]
+
 561.1001, found 561.0983. 
 
 
Ethyl 4-bromo-5-hydroxy-7-methoxy-6-methyl-2-oxo-2,3-dihydrobenzofuran-3-
carboxylate (187) and diethyl 2-(2-bromo-3,6-dihydroxy-5-methoxy-4-
methylphenyl)malonate (186). To the quinone (50.1 mg, 190 µmol) and diethyl 
malonate (29.1 µL, 190 µmol) in THF (2.0 mL) at 0 °C was added sodium hydride 
(9.4 mg, 390 µmol). The resulting dark blue reaction mixture was stirred at 0 °C for 
30 min and then sodium borohydride (14.5 mg, 380 µmol) was added. The reaction 
mixture was allowed to warm to rt. After TLC showed complete conversion of starting 
material, the reaction was quenched with 3M HCl at 0 °C. After stirring at rt for 30 min, 
diethyl ether was added and the layers were separated. The aqueous later was extracted 
with Et2O. The organic layers were dried, filtered and concentrated. The crude residue 
was passed through a silica plug (eluted with dichloromethane, then with 5% methanol in 
dichloromethane) to afford the lactone (35.1 mg, 53%) and the diester (20.1 mg, 27%). 
Ethyl 4-bromo-5-hydroxy-7-methoxy-6-methyl-2-oxo-2,3-dihydrobenzofuran-3-
carboxylate (187). Rf = 0.48 (50% EtOAc/ hexanes); IR (film) 3474, 2924, 1811, 1741, 
1480, 1424, 1305, 1132, 1113 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.40 (s, 1H), 4.60 (s, 
1H), 4.30 (q, J = 7.1 Hz, 2H), 3.99 (s, 3H), 2.22 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H); 
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13
C NMR (125 MHz, CDCl3) ppm 168.2, 163.9, 148.0, 142.4, 138.5, 121.2, 119.5, 99.1, 
63.2, 60.6, 52.6, 14.1, 10.2; HRMS (ESI): Exact mass calcd for C13H13O6BrNa [M+Na]
+
 
366.9793, found 366.9807.  
Diethyl 2-(2-bromo-3,6-dihydroxy-5-methoxy-4-methylphenyl)malonate (186). Rf = 
0.50 (5% MeOH/dichloromethane); IR (film) 3443, 2937, 1736, 1461, 1420, 1303, 1178, 
1086 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 6.65 (br s, 1H), 5.32 (br s, 1H), 5.18 (s, 1H), 
4.26 (q, J = 7.1 Hz, 4H), 3.80 (s, 3H), 2.23 (s, 3H), 1.28 (t, J = 7.1 Hz, 6H); 
13
C NMR 
(125 MHz, CDCl3) ppm 168.5, 147.4, 145.0, 142.6, 119.7, 118.6, 107.9, 62.4, 61.0, 55.1, 
14.1, 10.4; HRMS (ESI): Exact mass calcd for C15H19O7BrNa [M+Na]
+
 413.0212, found 
413.0230.  
 
 
Diethyl 2-(2-bromo-5-methoxy-4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)malonate 
(185). To a solution of the quinone (25.0 mg, 95.7 µmol) and malonate (15.0 µL, 
98.8 µmol) in THF (1.0 mL) at 0 °C was added sodium hydride (20.3 mg, 846 µmol). 
After 3 h, the reaction mixture was quenched with satd aq NH4Cl. The aqueous layer was 
extracted with ethyl acetate. The organic layers were combined, dried, filtered and 
concentrated. Column chromatography (SiO2, 20% ethyl acetate in hexanes) afforded the 
title compound as an orange oil (30.8 mg, 83%). Rf = 0.15 (10% EtOAc/ hexanes); IR 
(film) 2982, 2932, 1745, 1666, 1303, 1251, 1164, 1032 cm
-1
; 
1
H NMR (600 MHz, 
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CDCl3) δ 4.95 (s, 1H), 4.26 (q, J = 7.1 Hz, 4H), 4.04 (s, 3H), 2.02 (s, 3H), 1.29 (t, 
J = 7.1 Hz, 6H) 
13
C NMR (150 MHz, CDCl3) ppm 179.8, 178.6, 165.6 (2C), 155.8, 
140.2, 139.3, 128.4, 62.5 (2C), 61.3, 54.6, 14.1 (2C), 9.9; HRMS (ESI): Exact mass calcd 
for C15H17O7BrNa [M+Na]
+
 411.0055, found 411.0062. 
  
